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ABSTRACT
COMPUTATIONAL FRAMEWORKS FOR MicroRNA FUNCTIONAL
ANALYSIS OF INTER-KINGDOM AND INDIRECT TARGETING

Mohammed Sayed
April 19, 2021

Genes are DNA sequences that encode the information needed to synthesize
molecules necessary for the function of the cell. Some genes are called protein-coding
genes because they have the code required to manufacture proteins. The expression of a
certain gene means its product (protein) is produced. Although some genes are not
protein-coding, they regulate the gene expression of other protein-coding genes. Of these,
microRNAs (miRNAs) are small RNA molecules that inhibit the expression of other
genes by binding to their mRNA transcripts. miRNAs have been shown to be linked to
several biological processes like development and diseases like cancer.
Recently, researchers have hypothesized that miRNAs are involved in the
regulation of the expression of genes from other species. Although tools to predict
miRNA target genes are available in the case when miRNAs and target genes belong to
the same species, to our knowledge there are no available tools to predict inter-kingdom
miRNA target genes (miRNA and target genes belong to two different kingdoms). To
address this limitation, we developed an efficient tool to predict potential gut bacterial
v

genes targeted by miRNAs from edible plants. We successfully predicted ginger miRNAs
that target two genes from a gut bacterial strain called Lactobacillus rhamnosus GG. To
maintain the efficiency of our tool while using a larger number of miRNAs and bacterial
strains, we used a hash-table to index the sequences of bacterial genes.
To predict the function of a miRNA, we start by compiling the list of direct target
genes (ones with binding sites) and then we search for biological process in which these
genes are enriched. This approach does not include other genes affected by the miRNA
but do not necessarily have a physical binding site (indirect targets). An example of an
indirect target is the gene that doesn’t have a binding site and is regulated through other
direct targets like transcription factors. To overcome this limitation, we developed
miRinGO an interactive web application to include these indirect targets in the functional
analysis. Our approach showed better performance compared to the existing approach in
predicting biological processes known to be targeted by certain miRNAs.
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INTRODUCTION

MicroRNAs (miRNAs) are small non-coding RNA sequences (21-24 nucleotides
long) that have a prominent role in gene regulation. MiRNAs mainly act posttranscriptionally by binding to mRNA transcripts and either inhibit translation (protein
synthesis) or initiate the degradation of the target transcript. Computational tools have
been introduced to predict potential target genes and biological processes affected by a
specific miRNA or a set of miRNAs. Despite extensive work in miRNA research, the full
spectrum of the role of miRNAs in gene regulation is still to be revealed.

1.1 Motivation
Typically, to predict the function of a miRNA, computational tools follow a twostep process. The first step is to identify the list of potential target genes and then they
identify biological processes that are enriched in these target genes. Although many tools
are developed to do each of the two steps, they have some limitations. For instance,
miRNA target prediction tools are species-specific (i.e. they are used to predict target
genes when miRNAs and targets belong to the same species e.g. human). Also, current
tools include only target genes with physical binding sites (direct targets) in the
enrichment step.
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In this dissertation, we discuss the need for computational tools to address interkingdom miRNA targeting (part I). We also discuss the motivation to develop new tools
for miRNA functional analysis (Part II).

1.1.1 Part I: inter-kingdom miRNA targeting
The overall goal of this project is to determine how edible plants (e.g. ginger and
broccoli) affect our gut bacteria and ultimately our health. Gut bacteria play an important
role in human health. For example, help digest hard-to-digest dietary fibers, defend the
host against harmful microorganisms, and synthesize essential vitamins and amino acids.
The imbalance of gut bacteria can lead to multiple diseases including inflammatory
bowel diseases (IBD), obesity, liver disease, and cancer.
Studies have shown that food including edible plants can affect the balance of gut
bacteria. Edible plant cells use secreted nanoparticles called exosomes to communicate
with other cells and tissues [1]. The cargo of exosomes includes different types of
molecules: proteins, DNAs, mRNAs, and miRNAs. Researchers hypothesize that
exosomes from edible plants may interact with gut bacteria.
MiRNAs play a role in the regulation of target gene expression even across
kingdoms [2]. In our case, we are dealing with two different kingdoms (plants and
bacteria), and each has its miRNA targeting mechanism. In animals, a limited number of
base-pairings (~ 7 bp) is sufficient for miRNA targeting. On the other hand, in plants
perfect (or near-perfect) base pairing between miRNA and mRNA sequences is required.
Although miRNAs have been shown to target gut bacteria [3], the actual mechanism is
still unknown. For the above reasons, new computational tools are needed to identify
cross-kingdom miRNA targets.
2

1.1.2 Part II: human miRNA functional analysis
To computationally predict miRNA-targeted biological processes, typically
potential target genes are compiled using one or more miRNA target prediction tools and
a standard gene enrichment analysis [4] is used to find potential biological processes
enriched in these genes. Although current tools are widely used, they have some
limitations. Of these, existing tools consider only direct targets (ones with physical
binding sites) of miRNAs but do not consider other targets that do not necessarily have
miRNA binding sites [5].

1.2 Dissertation Contributions
To address the aforementioned limitations, we developed the following
computational frameworks.

1.2.1 A framework for inter-kingdom miRNA targeting
Given the importance of the miRNA seed region in targeting mechanisms in
different kingdoms, animals, plants, and viruses, we developed a seed-based miRNA
targeting framework to find potential gut bacterial genes targeted by edible plant
miRNAs. In this framework, first gut bacterial genes were searched for potential plant
miRNA binding sites. Then, we employed a technique proposed by Murphy et al. [6],
initially to predict targets of viral miRNAs, to identify target genes with enriched binding
sites. We showed that using our tool we can identify ginger miRNAs that target genes
from Lactobacillus rhamnosus GG (LGG) bacteria. To validate our results, two miRNAs
have been experimentally validated to downregulate and bind to two LGG genes.
3

1.2.2 A web application for human miRNA functional analysis
We developed, miRinGO, an interactive R Shiny application [7] to predict
potential biological processes both directly and indirectly targeted by human miRNAs. In
addition to a list of top-ranked biological processes, the web application gives the user a
visual summary of the results. It is freely available from GitHub at
https://github.com/Fadeel/miRinGO

1.3 Dissertation Outline
The remainder of this dissertation is organized as follows. Chapter 2 provides an
introduction to molecular biology and miRNA targeting techniques. Chapter 3 introduces
a proposed method to predict potential gut bacterial genes targeted by edible plant
miRNAs. Chapter 4 introduces the proposed framework to find biological processes
indirectly targeted by miRNAs in humans. Chapter 5 provides conclusions and potential
future work.
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BACKGROUND AND LITERATURE REVIEW

2.1 Introduction to molecular biology
2.1.1 Living organisms and cells
It is estimated that there are more than 10 million different living species on Earth
[8]. The building block of these organisms is the cell. Although the cell size can vary
from 1µm (bacteria) to 100 µm (plants), all cells share mainly two characteristics [9].
First, the ability to take up nutrients from the environment and converting them to other
molecules and energy. Second, the ability to make many copies of themselves and
passing genetic material to their offspring.
Some organisms are composed of single cells like bacteria but other species like
humans can have up to 1013 cells. Cells can be categorized into two types: prokaryotic

and eukaryotic. Prokaryotic cells do not have a nucleus and on the other hand, eukaryotic
cells have a nucleus where it contains the cell’s DNA. Prokaryotes include bacteria and
archaea. Animals, plants, and fungi are examples of eukaryotes.
Cells are surrounded by fat-based molecules (phospholipids) forming what is
called the cell membrane (or plasma membrane) [10]. Inside the cell membrane, cellular
machinery and other structural units exist within a water-based environment called
cytoplasm. Cells contain a variety of molecules including nucleic acid, proteins,
carbohydrates, and lipids. Nucleic acids and proteins will be discussed in more detail
below.
5

Figure 2-1: Eukaryotic and prokaryotic cells [11]

2.1.2 Nucleic acids
Nucleic acids are the molecules that contain genetic information. There are two
types of nucleic acids: deoxyribonucleic acid (DNA) and ribonucleic acid (RNA).
2.1.2.1 DNA
DNA consists of a sequence of smaller molecules called nucleotides [10]. Each
nucleotide contains three molecules: a nitrogenous base, a sugar molecule, and a
phosphate group. There are four different DNA nucleotides based on the nitrogenous
base: adenine (A), thymine (T), cytosine (C), and guanine (G) as shown in Figure 2-2.
Although DNA can be found as single-strand polynucleotides, it is more stable
when two strands come together and bases from one strand are bound (paired) to the
complementary bases for the other strand via hydrogen bonds as shown in Figure 2-3.
Each “A” from one strand always pairs with a “T” from the other strand and each “G”
from one strand pairs with a “C” from the other strand.
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Figure 2-2: chemical structure of nucleotides [12]

Figure 2-3: DNA base pairing [12]
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2.1.3 Proteins
Proteins are large molecules that contribute to a cell’s function and structure. For
example, structural proteins maintain cell shape and are part of structural elements of
connective tissues like cartilage and bone [13]. Other proteins called enzymes work as
catalysts for biochemical reactions within the cell. Another category of proteins are
attached to the cell membrane and have diverse functionality e.g. transporting molecules
from/to the cell, activating an intracellular process upon receiving an extracellular signal
or attach the cell to a specific location.

Figure 2-4: Example functions of membrane proteins [10]
Each protein consists of a series of building blocks called amino acids. Each
amino acid consists of a central carbon atom, an amino group, a carboxyl group, a
hydrogen atom, and a side chain. Multiple amino acids are bound together by peptide
bonds to form a long chain of polypeptides or a protein as shown in Figure 2-5. The
linear sequence of amino acids is considered the primary structure. Protein’s primary
structure determines its conformation and ultimately the three-dimensional shape.

8

Figure 2-5: Protein building blocks [10]

2.1.4 The central dogma of molecular biology
The term “central dogma” was coined by Francis Crick in 1956 to describe the
flow of information (genetic code needed to form a protein) from DNA to protein. It
states that
“once information has got into a protein it can’t get out again” [14].

9

The information flow was classified into three categories. General transfers occur
in most cells and include DNA  DNA, DNA RNA, and RNA  protein. Special
transfers occur under specific conditions and include the following transfers RNA
RNA, RNA  DNA, and DNA  protein. The last category includes transfers unlikely
to occur (protein  protein, protein  RNA, and protein  DNA).

2.1.5 Genes and gene expression
Genes are DNA sequences that encode the information needed to synthesis a
protein. In humans, a child inherits a copy of the same gene from each parent. Genes are
expressed when their corresponding proteins are manufactured [15]. Gene expression
process goes through two main steps: DNA transcription and translation as shown in
Figure 2-6.
DNA transcription is the process in which information required for protein
synthesis is transferred to an intermediate molecule called messenger RNA (mRNA). The
transcription process is initiated by an enzyme called RNA polymerase where one strand
of DNA is used as a template [16].
During translation process, the genetic code in the mRNA molecule is read
sequentially to produce a linear chain of amino acids (protein). With help of translation
machinery called the ribosome, every three nucleotides in mRNA correspond to one
amino acid according to a specific code as shown in Figure 2-7.

10

Figure 2-6: Gene expression process [15]

Figure 2-7: Genetic code [15]
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2.1.6 Regulation of gene expression
The process of gene expression involves decoding genetic instructions encoded in
the DNA to synthesize proteins. The set of proteins expressed in a cell determines the
structure and function of this cell. Although all cells in a multicellular organism (e.g.
animals, plants, …) have the same copy of the DNA sequence, different sets of genes are
expressed in different cell types and some genes are only expressed in a specific cell type,
for example, Hemoglobin (which is used to carry oxygen) is expressed specifically in red
blood cells. Another protein, tyrosine aminotransferase (which is used to break down
tyrosine in food), is specifically expressed in liver cells [8].
The process of gene expression goes through multiple steps from DNA to proteins
through RNA, therefore the amount of expression can be controlled at each step. There
are multiple levels of regulation as detailed below.
2.1.6.1 Epigenetic alterations
In which genes are switched on or off without genetic changes (changes in DNA
sequence) but in response to external factors like development, aging, exercise, and diet
[17]. There are two main types of epigenetic changes as shown in Figure 2-8. The first
mechanism is called methylation and is facilitated by adding a methyl group to a DNA
molecule. If specific regions in the DNA (for example promotor regions) are methylated,
this will repress the expression of the nearby gene. The second mechanism which is
called histone modification happens when chemical groups are added to histones. Since
DNA is wrapped around histones, these modifications can determine which genes are
available for expression (unwrapped) or turned off (wrapped).

12

Figure 2-8: Epigenetic mechanisms for gene regulation [18]

2.1.6.2 Transcriptional regulation
In addition to epigenetic mechanisms, a group of protein-coding genes called
transcriptional regulators (factors) activate or repress the expression of a gene by binding
to a specific DNA sequence usually 5-10 nucleotides near that gene. This binding
initiates a sequence of reactions that determines which genes to be transcribed and
additionally the rate of transcription [19].

13

Figure 2-9: Transcription factors initiate the control of gene expression [20]

2.1.6.3 Alternative splicing
Transcription of a gene from a DNA sequence produces a long RNA transcript
called precursor mRNA (pre-mRNA) transcript. Pre-mRNA transcripts typically undergo
a process called RNA splicing in which non-coding sequences of the gene (introns) are
removed and protein-coding sequences (exons) are joined back together to form mature
RNA (mRNA) transcript [21] that has the code to synthesis a specific protein. Some
genes are alternatively spliced meaning that some exons are either included or excluded
in the final mRNA transcript. Alternative splicing (AS) makes it possible for a single
gene to produces multiple proteins as shown in Figure 2-10.
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Figure 2-10: An example of an alternatively spliced gene [22]

2.2 MicroRNAs
MicroRNAs (miRNAs) are small non-coding RNA molecules that are ~22
nucleotides and are known to be involved in the regulation of the expression of other
protein-coding genes (target genes) and have an essential role in many biological
processes including development and diseases like cancer. The first miRNA was
discovered in Caenorhabditis elegans (C. elegans) (the worm) in 1993 [23] [24] by
Ambros and Ruvkun groups [25]. This miRNA (lin-4) was found to be essential to the
normal development of C. elegans by regulating the expression of the lin-14 protein.

2.2.1 Biogenesis of miRNAs
miRNA genes can be found within introns of other protein-coding genes
(Mitrons) or independent from other genes (intergenic miRNAs) [25]. Biogenesis of
miRNAs starts with transcribing miRNA genes into primary transcripts (pri-miRNAs)
using RNA polymerase II/III. Processing of pri-miRNAs to produce mature miRNAs

15

follows different pathways depending on the locus of the miRNA gene as shown in
Figure 2-11.
In the canonical pathway, longer pri-mRNA transcripts (~1K nucleotides) are
processed by a microprocessor complex, consists of two proteins (DGCR8 and Drosha)
to produce a transcript with a stem-loop structure known as pre-miRNA (~60 nucleotides
in animals). After producing pre-miRNAs, they are exported to the cytoplasm where the
loop is removed by Dicer protein, and the double-stranded RNA is released. Each strand
of the mature miRNA can be loaded into one of the Argonaute (AGO) family of proteins
to form a miRNA-induced silencing complex (miRISC).
In the non-canonical pathway, some intronic sequences following the splicing
process have the structural features of pre-miRNAs, therefore bypassing the Droshamediated processing [26].

16

Figure 2-11: Different pathways of animal miRNA biogenesis [27]

2.2.2

MicroRNA targeting mechanism in animals
The following papers in this section cover the process of miRNA-based gene

silencing in animals. Such information could enhance the performance of tools developed
for the computational prediction of miRNA targets.
Cisse, et al. [28] addressed the question of what the minimum number of basepairings is needed to establish a stable association of two DNA/RNA strands. This could
be used to infer some of the rules governing small RNA-based gene silencing, including
miRNA-based gene regulation. To answer this question, they synthesized 8 nucleotides
(nt) sequences representing the seed of human miR125 with mismatches at the 1st nt
17

(leaving 7 contiguous nts) and at the 2nd nt (leaving 6 contiguous nts). The association
rate with seven contiguous nts was 450 times bigger than the one with 6 nts. This finding
supports the hypothesis that at least seven Watson-Crick base pairs in the miRNA seed
region are needed for rapid and effective targeting.
Wee, et al. [29] provided an insight into how the Argonaute (Ago2) protein in
RISC (RNA-induced silencing complex) shapes the miRNA guide. They showed that
Ago2 divides a miRNA sequence into five functional domains. These domains are the
anchor (1st nt), seed (2nd – 8th nt), central (9th – 12th nt), 3’ supplementary (13th – 16th nt),
and tail region (17th – 21st nt). Their results showed that the miRNA-guided silencing
complex is used for translation inhibition without cleaving target mRNA transcript. On
the other hand, small-intervening RNAs (siRNAs) are responsible for mRNA cleavage.
Unlike mismatches at the seed ends, mismatches in the center of the seed regions are not
favorable for effective gene silencing. Although G-U wobbles in the seed region were
considered by existing miRNA target prediction tools, this paper suggests that G-U
wobbles should be treated like mismatches and should not be allowed.
Salomon, et al. [30] studied the binding properties of guide RNA that are bound
to Ago protein within the RISC complex. They found that seed nucleotides [2nd – 5th nt]
are involved more at the initial binding to target mRNA and then Ago is conformed to
expose nucleotides [6th – 8th nt] and [13th – 16th nt] for more stable binding. Also,
Extensive binding on the 3’ end could compensate for mismatches in the seed region [4th
– 5th nt]. They also suggested that the binding of nucleotides [9th, 10th] of miRNA should
be penalized in miRNA target prediction algorithms due to the unfavorable conformation
in Argonaute.
18

Broughton, et al. [31] investigated the specificity of seed-based miRNA targeting.
To answer this question, they used individual-nucleotide resolution cross-linking
immunoprecipitation (iCLIP) to extract miRNA-target chimeras by ligating each miRNA
to its target. Since miRNA families have common seed regions but different 3’
sequences, they were used to determine if all miRNAs in a family have common targets
or not. The results suggest that miRNA family members have shared targets in addition to
targets specific to each member. This paper highlights the importance of pairing the
miRNA 3’ supplementary sequence for enhancing the predictive power of current
miRNA target prediction tools.
Chandradoss, et al. [32] studied how the Ago protein finds target sites in mRNA.
They used a single-molecule FRET (Förster resonance energy transfer) assay to visualize
the search process used by Ago2 to find miRNA target sites. They found that the
miRNA-bound Ago employs a lateral diffusion mechanism for searching and identifying
target sites. First, the sub-seed region [nt 2-4] is used for initial searching and once a
complete seed pairing is found [nt 2-8], the binding becomes stable. This model suggests
that target regions might be enriched in the trinucleotides [nt 2-4] of the seed region
which could be an additional feature to be added to miRNA target prediction tools.

19

2.2.3 Computational prediction of miRNA targets in animals
Saito et al. [33] discussed six main features currently used by miRNA target
prediction tools. These features are listed as follows,
1. miRNA-mRNA base pairing at the 5’ miRNA seed region [1st to 8th
nucleotide]: this feature is considered the most relevant feature used by the silencing
complex to find target genes. Stringent seed paring is considered more effective than seed
pairing with mismatches.
2. Location of target sites within mRNA transcript: although miRNA-guided
silencing complex may target 5’UTR and CDS regions, the 3’UTR contains most of the
target sites.
3. Conservation of miRNAs and their targets: miRNA targets tend to be in regions
conserved among closely related species. Using conservation information in miRNA
target prediction tools could increase specificity. Of course, this increase occurs with a
cost to sensitivity.
4. Site accessibility: to enable miRNA-mRNA hybridization, a target site must be
easily accessible. Estimation of site accessibility can be achieved by calculating the
minimum free energy of an mRNA secondary structure. Although theoretically, an
mRNA secondary structure with the minimum free energy is most likely to occur
naturally, this might not be the actual structure because RNA secondary structure is
dynamic [34]. Also, the computational complexity of these algorithms is 𝑂𝑂(𝑛𝑛3 ) [35],
where n is the length of the RNA transcript.

5. Multiple target sites Having more than one potential miRNA target site could

enhance the role of miRNA as a translation inhibitor as it increases the chances of
binding of silencing complex and mRNA transcript.
6. Expression profiles of miRNAs and mRNAs: due to their role in translation
inhibition and mRNA degradation, the expression of miRNAs is expected to be
negatively correlated with the expression of targeted mRNAs. Although using this feature
could help exclude some of the false positives, it could overlook some true miRNAmRNA pairs that are negatively correlated at the protein level only.
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Saito et al. [33] provided a useful comparison of approximately 30 different
prediction tools based on the presence or absence of these six features. On the other hand,
it did not provide a performance analysis (accuracy and computational complexity) for
these tools.
Bradley, et al. [36] provided a review of two classes of miRNA target prediction
tools, namely, classical tools and tools trained by data generated from CLIP (crosslinking and immunoprecipitation) or CLIPL (cross-linking and immunoprecipitation and
ligation) high-throughput experiments. This new class of prediction tools (CLIP &
CLIPL-based) is an improvement in the identification of transcriptome-wide miRNA
targets.
In CLIP-based experiments, RNAs bound to the AGO protein are directly
sequenced, but there is still ambiguity linking specific miRNA to a specific mRNA.
Although CLIPL-based experiments use a similar process, an additional step is added that
ligates a miRNA to its mRNA fragment. By sequencing miRNA-mRNA chimeras, a
specific miRNA can be linked to its target site.
Although the high-throughput nature of CLIP&CLIPL experiments makes it
suitable for training machine learning-based target prediction algorithms, these methods
still suffer from technical difficulties that require well-trained personnel to manage.
Another issue with these experiments is that several non-canonical target sites (seed
pairing with mismatches and bulges) have been reported, which are thought to be
ineffective sites.
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Fan, et al. [37] provided an overview of 38 sequence-based miRNA target
prediction tools and a comparison of seven popular tools based on their predictive
performance, ease of use, availability, and impact. The authors compared TargetScan 6.2
[38], PicTar [39] , DIANA-microT-CDS [40], miRanda [41], EIMMo3[42], mirTarget2
v4 [43], miRmap v1.1 [44]. They assessed the predictive performance based on four
different datasets, duplex-level (the actual site within mRNA transcript), gene-level,
mRNA expression-level, and protein-level.
The results of these assessments suggest that there is no globally best tool.
Although TargetScan and miRmap provided high overall predictive performance, PicTar
and MirTarget2 showed high specificity. As expected, gene-level prediction performance
was better than duplex-level predictions, as gene-level predictions can make use of more
information (enrichment of multiple seed pairings). Finally, many (>83%) of nonfunctional target sites have at least 6bp in their seed-pairings, which makes the miRNA
target prediction more challenging.
Oliveira, et al. [45] focused on finding the best approach for using miRNA
prediction tools. The authors argue that the current trend of using the intersection of
targets identified with different prediction tools is not the best way to combine results, as
this approach suffers low sensitivity and often misses many true targets. To address this
question, they compared the targets generated from four different individual tools
(TargetScan [46], miRanda-mirSVR [41], Pita [47], and RNA22 [48]) and the
intersection/union of different subsets of these tools. In terms of prediction performance,
the authors suggest using the union of target prediction results from Targetscan and
miRanda when high specificity is needed and the union of target prediction results from
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Targetscan, miRanda, and RNA22 if higher sensitivity is need while preserving good
specificity. Although this paper addressed a practical aspect to solve the miRNA target
prediction problem, it has some limitations. For its test dataset, true negatives were
defined as those that are neither validated (according to mirTarbase database) nor
predicted. However, this assumption is not accurate since some true targets might not be
validated till this point in time Also, they did not provide a plausible explanation for why
this particular combination of tools might have the best predictive performance.
Gumienny, et al. [49] introduced MIRZA-G tool for predicting miRNA targets
and siRNA off-targets. Since siRNA off-target sites are not likely to be conserved, using
conservation-based miRNA target prediction tools is not suitable. In addition to the
classical features (site accessibility, position within 3’UTR, flanking G/flanking U
content, conservation information), MIRZA-G employs miRNA-target interaction energy
as a new feature. A logistic regression model was used to predict the efficacy of the target
site based on the previous features.
Agarwal, et al. [46] introduced the prediction model used in the latest version of
TargetScan (v7). Although TargetScan is considered the leading tool for miRNA target
prediction, previous versions were mainly focusing on conserved target sites which
reduces its sensitivity and increases the likelihood of missing siRNA off-targets. The new
multiple regression model employs 14 features and covers information regarding seed
type, context around the target site, 3’ pairing, target transcript, and site accessibility.
Since TargetScan considers only canonical seed types (no mismatches or GU
wobbles), the authors examined the efficacy of non-canonical target sites which are
abundantly discovered in the new CLIP-based experiments. Surprisingly, they found that
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these sites are not functional concerning translation inhibition. Although the proposed
model surpassed other miRNA target prediction tools, there are still some limitations.
First, despite being simple and easy to interpret, the multiple regression model assumes
that there is a linear relationship between target site efficacy and each of the input
features which may not be the case for some features. Second, regarding test data, only
gene expression at the mRNA level was used which may not be sufficient for detecting
translation inhibition. Third, only target sites within the 3’UTR are included which could
miss other functional targets in the CDS/5’UTR regions.
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3

PREDICTION OF POTENTIAL BACTERIAL GENES TARGETED BY PLANT
MIRNAS

3.1 Introduction
Previous studies have shown the role of small non-coding RNAs especially
miRNAs in the regulation of cross-kingdom gene expression. As described in Liang, et
al.’s study [50], cross-kingdom regulation occurs when a microRNA and a target gene
belong to two different species (e.g., different kingdoms such as animals, plants, bacteria,
viruses, etc.).
Although the way cells within the same species communicate is known (e.g.
communication between neurons through hormones in humans [51]), the way cells from
two different species exchange signals was not discovered until recently.
In this chapter, we propose a computational framework to investigate a new type
of cross-kingdom gene regulation by predicting potential gut bacterial genes targeted by
edible plant miRNAs (e.g. ginger miRNAs).

3.2 Background
3.2.1 Cross-kingdom gene regulation
Liang, et al.’s study [50] provided four different examples of the new role of
miRNA in cross-kingdom gene regulation. Firstly, Plant miRNAs were found to exist in
human tissue and sera and at relevant concentrations. Of these plant miRNAs, MIR168a
was shown to target low-density lipoprotein receptor adaptor protein 1 (LDLR AP1) [52].
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Also, Human miRNAs were found within the malaria parasite Plasmodium
falciparum and were shown to affect its growth [53]. On the other hand, Viral miRNA
KSHV-miR-K12-11 was found to mimic and share common targets with human miRNA
miR-155 [54]. Lastly, Human miRNA miR-122 has a role in stimulating the replication
of the hepatitis C virus by stabilizing its viral RNA and prevent its degradation [55] by
targeting two 5’ UTR sites.
Liu et al. [3] provided additional evidence of the role of cross-kingdom miRNAbased gene regulation. They showed that human miRNAs from epithelial and other cells
can enter gut bacteria and affect its growth. They also discussed how miRNAs
manipulate the composition of the gut microbiota. Interestingly, they mentioned that
miRNAs could target ribosomal RNAs, and they could either repress or promote gene
expression.

3.3 Methods
3.3.1 Datasets
Top 49 expressed ginger miRNAs (Appendix I) are detected from miRNA-seq
data of exosomes-like nanoparticles (SRA accession numbers SRX5085431,
SRX5085432, SRX5085433). Reference genome sequences of 8 common gut bacteria
(see Table 3-1) were downloaded from NCBI RefSeq database [56]
(ftp://ftp.ncbi.nlm.nih.gov/genomes/refseq/bacteria/)
Table 3-1: Common gut bacteria and their RefSeq accession numbers
Bacterial strain
Akkermansia muciniphila
Bacteroides fragilis
Clostridium perfringens

NCBI RefSeq Accession Number
NC_010655.1
NC_006347.1
NC_008261.1
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NC_000913.3
NC_004668.1
NC_000915.1
NC_013198.1
NC_015975.1

Escherichia coli
Enterococcus faecalis
Helicobacter pylori
Lactobacillus rhamnosus GG
Lactobacillus ruminis

3.3.2 Overall pipeline
Our pipeline (Figure 3-1) takes as inputs sequences of plant miRNAs and
sequences of bacterial genes. Then, for each miRNA-gene pair, we search for hits for
both miRNA seed and its reverse complement (This because miRNAs can target both
bacterial DNA and mRNA [3]). For fast searching, bacterial gene sequences are indexed
into a hash-table as detailed in the next section. Finally, for each miRNA-gene, we
compare the actual number of hits with the expected number to find genes with enriched
miRNA seed binding sites.

Figure 3-1: Overall pipeline to detect potential bacterial genes targeted by plant miRNAs
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3.3.3 Hash table-based miRNA seed binding site detection
Let T represents the sequences of bacterial genes, p to the pattern (e.g. miRNA
seed sequence) we are searching for in T, and H(p) to be the hash function that converts p
into an integer number. Our hash table will have H(k-mer) (where k-mer is a subsequence
of length k of text T ) as key and a list of locations of this p in T as value as shown in
Table 3-2
Since our set of keys are static and relatively not too big (for example, the set of
all 48 possible 8-mers if k = 8), we use a perfect hash function, where each key is

mapped to a unique row without collisions. Since DNA/RNA has 4 different nucleotides
(A, C, G, T/U), their integer representation can be as follows I(A) = 0, I(C) = 1, I(G) = 2
and I(T) = 3. Then the hash value of pattern p of length k (k-mer) can be calculated as
follows,
𝑘𝑘−1

𝐻𝐻(p) = �� 𝐼𝐼(𝑝𝑝[𝑖𝑖]) × 4𝑖𝑖 �
𝑖𝑖=0

For example, 𝐻𝐻(′𝐴𝐴𝐴𝐴𝐺𝐺 ′ ) = 2 × 40 + 3 × 41 + 0 × 42 = 14.

Table 3-2: Target bacterial gene sequences represented as a hash table
Key

Value

…

…

H(‘ATACACTG’)

[<gene1,offset>, <gene656,offset>]

…

…

H(‘CATCAGGG’)

[<gene100,offset>, <gene45,offset>, <gene98,offset>]

…

…
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3.3.4 Enrichment analysis
In order to find bacterial genes that are more likely to be targeted, we employ a
technique proposed by Murphy et al. [6] initially to predict targets of viral miRNAs. To
quantify overrepresentation (enrichment) of a k-mer in a sequence, the actual count
𝐶𝐶𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑙𝑙 is compared to an expected count 𝐶𝐶𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 (how many times we expect to see
this k-mer X by chance). 𝐶𝐶𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 is calculated by the following equation,
𝐶𝐶𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 = (𝐿𝐿 − 𝑘𝑘 + 1) × 𝑃𝑃(𝑋𝑋)

Where P is the probability of seeing this k-mer in a target sequence of length L
given a specific model of this sequence. We use a first-order Markov chain of the target
sequence to model it. P can be calculated using the following equation,
𝑘𝑘

𝑃𝑃(𝑋𝑋) = 𝑝𝑝(𝑥𝑥1 ) � 𝑝𝑝(𝑥𝑥𝑖𝑖 | 𝑥𝑥𝑖𝑖−1 )
𝑖𝑖= 2

Where 𝑥𝑥𝑖𝑖 is nucleotide at position 𝑖𝑖 of k-mer X, 𝑝𝑝(𝑥𝑥𝑖𝑖 | 𝑥𝑥𝑖𝑖−1 ) is the probability of

having nucleotide 𝑥𝑥𝑖𝑖 after nucleotide 𝑥𝑥𝑖𝑖−1 and can be represented as a matrix (Figure 3-2)

and 𝑝𝑝(𝑥𝑥1 ) is probability of seeing nucleotide 𝑥𝑥1 .
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Figure 3-2: Example of 1st order Markov chain for a DNA sequence
For example, if X = ‘ATGC’, then the probability of seeing this 4-mer given the 1st order
Markov chain model in Figure 3-2 will be calculated as follows,
𝑃𝑃(′𝐴𝐴𝐴𝐴𝐴𝐴𝐶𝐶 ′ ) = 𝑝𝑝(𝑥𝑥1 )[ 𝑝𝑝(𝑥𝑥2 | 𝑥𝑥1 ) × 𝑝𝑝(𝑥𝑥3 | 𝑥𝑥2 ) × 𝑝𝑝(𝑥𝑥4 | 𝑥𝑥3 ) ]

𝑃𝑃(′𝐴𝐴𝐴𝐴𝐴𝐴𝐶𝐶 ′ ) = 𝑝𝑝(′𝐴𝐴′)[ 𝑝𝑝(′𝑇𝑇 ′| ′𝐴𝐴′) × 𝑝𝑝(′𝐺𝐺′ | ′𝑇𝑇′) × 𝑝𝑝(′𝐶𝐶′ | ′𝐺𝐺′) ]
𝑃𝑃(′𝐴𝐴𝐴𝐴𝐴𝐴𝐶𝐶 ′ ) = 0.25 [0.3 × 0.4 × 0.2 ] = 0.006

And if we assume that the length of the target sequence (L) is 1000, then the expected
count 𝐶𝐶𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 will be 1000× 0.006 which is 6.

Using first-order Markov chain allows us to capture any dinucleotide biases, for

example, CG content. Also, given that the average length of a bacterial gene is ~900,
there may not be long enough to train higher-order chain models
To quantify the likelihood of one miRNA to target a specific target gene, we
calculate Pvalue. Assuming a binomial distribution, Pvalue is the probability of having at
least 𝐶𝐶𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 binding sites and is calculated by the following formula,
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𝐿𝐿−𝑘𝑘+1

𝑃𝑃value = � �
𝑖𝑖=𝐶𝐶𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎

𝐿𝐿 − 𝑘𝑘 + 1
� 𝑃𝑃(𝑋𝑋)𝑖𝑖 (1 − 𝑃𝑃(𝑋𝑋))𝐿𝐿−𝑘𝑘+1−𝑖𝑖
𝑖𝑖

3.4 Results
3.4.1 Identification of potential gut bacterial genes targeted by ginger miRNAs
Bacterial mRNAs potentially targeted by ginger miRNAs were identified by
enrichment analysis of the reverse complement of the miRNA seed sequence (8mer =
nucleotides 1 – 8 from 5’ end) in the coding sequence (CDS). The enrichment analysis
adopted a framework that utilizes the 1st order Markov model (MM). In this framework,
the observed 8mer count in the CDS region of each bacterial mRNA was compared
against the background count derived from the 1st order Markov chain model. A p-value
was calculated for each miRNA-mRNA pair to estimate the likelihood of having a
functional pair. Once all p-values were calculated, the false discovery rate (FDR) was
obtained using the Benjamini–Hochberg method [57] for multiple p-value correction.
Table 3-3: Number of potential genes targeted by ginger miRNAs
Bacterial strain
Akkermansia muciniphila
Bacteroides fragilis
Clostridium perfringens
Escherichia coli
Enterococcus faecalis
Helicobacter pylori
Lactobacillus rhamnosus
GG
Lactobacillus ruminis

Number of
potential target
genes
677
1088
320
1168
866
372

Percentage of total
genes (%)

726
429
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GC content (%)

30.0
26.5
11.2
26.7
32.5
24.5
28.1

55.8
43.1
28.4
50.8
37.5
38.8

21.3

43.3

47.0

Table 3-3 shows that hundreds of bacterial genes are potentially targeted by
ginger miRNAs. The percentage of potentials targets varies for different bacterial strains
and ranges from 11.2% for Clostridium perfringens to 32.5% for Enterococcus faecalis.
To see if these variations are related to the nucleotide composition of different bacterial
genomes, we calculated GC content of each of these genomes. Some bacterial genomes
with high GC content like Akkermansia muciniphila, Escherichia coli, and Lactobacillus
rhamnosus GG tend to have a higher percentage of potential target genes. On the other
hand, bacterial genomes with a low percentage of potential target genes like Clostridium
perfringens has low GC content.

3.4.2 Case study 1: Ginger miRNA ath-miR167a-5p targets LGG SpaC gene
Using the top 49 expressed miRNAs from ginger exosomes, we used our tool to
find potential bacterial (LGG strain) genes targeted by these miRNAs. We search for
potential binding sites for the miRNA seed region (7mer) in both reverse and forward
strands (targeting at the DNA level [3]). Of these genes, LGG pilus gene SpaC has a role
in the colonization of bacteria into host tissues [58]. Table 3-4 shows potential ginger
miRNAs targeting the LGG pilus gene. Only six miRNAs have potential binding sites in
SpaC coding sequence. Of these, miR-167a-5p has shown significant targeting (p-value <
0.05) with 2 potential seed binding sites.
Teng et al. [59] showed that SpaC gene is downregulated at both transcriptional
and protein levels when LGG was treated by ginger exosomes. Also, the authors showed
that scrambled miR-167a-5p (with mutations at seed region) did not affect the expression
of SpaC.
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Table 3-4: potential ginger miRNAs targeting pilus gene (SpaC)
miRNA ID

seed (7mer)

# of hits

length of
transcript

p-value

ath-miR167a-5p

GAAGCTG

2

2688

0.0118

ppt-miR319a

TTGGACT

1

2688

0.1496

mdm-miR535a

GACAACG

1

2688

0.2078

aly-miR396a-3p

TTCAATA

1

2688

0.2473

gma-miR396a-3p

TCAATAA

1

2688

0.2566

aly-miR166a-5p

GAATGTT

1

2688

0.2664

3.4.3 Case study 2: Ginger miRNAs targeting LGG lexA gene
Teng et. al. [59] showed that lexA gene is downregulated at both transcriptional
and protein levels when LGG was treated by ginger exosomes. To find potential ginger
miRNAs targeting LGG lexA gene, we searched for potential binding sites for all 13
miRNA seed regions with length equals to 8 nucleotides (with different start positions
from the 5’ end). We found that only miRNA seeds from miR396 microRNA family have
potential binding sites on LGG lexA sequence as shown in Table 3-5.
Table 3-5: potential Ginger miRNAs targeting lexA gene
miRNA ID

Seed (8mer)

miRNA seed
start site

Target start
site

length of
transcript

aly-miR396a-5p

TTTCTTGA

10

427

626

gma-miR396e

TTTCTTGA

10

427

626
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aly-miR396b-5p

TTTCTTGA

10

427

626

osa-miR396d

TTTCTTGA

10

427

626

gma-miR396h

TTTCTTGA

9

427

626

3.4.4 Computational complexity analysis
To evaluate the computational complexity of the proposed method, we run our
program to search for potential binding sites of nucleotides 10 to 17 (8 nucleotides) from
the 5’end of the miRNA sequence in different numbers of human gut bacterial genomes
(1 to 8 strains) to see how the program scales with more input sequences. We also used
different orders of the Markov chain models (0th to 4th order) to measure the effect of
model order on the program performance. Running time was measured using cProfile
Python package. For each combination of parameters (number of bacterial genomes and
model order), we repeated the experiment 3 times and calculated the average run time.
Figure 3-3 shows that running time linearly increases with an increased number of
bacterial genomes. Using higher-order Markov chain models to model bacterial
sequences slightly increased the run time, 4th order models.
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Figure 3-3: Average running time with different number of bacterial genomes and
Markov chain model order
We also wanted to measure the effect of the number of input miRNA seeds (query
patterns) on the run time of hashing-based pattern searching algorithm. We used different
numbers of query patterns (1 to 41 miRNA seeds) and different numbers of target
sequences (1 to 6 bacterial genomes). Note that for this experiment, we only included the
pattern searching step and excluded other steps (e.g. counting of the number of hits,
enrichment analysis using Markov chain models, and writing results to output files).
Figure 3-4 shows that the average run time of the hashing-based pattern searching
method remains almost constant with increasing the number of miRNAs. On the other
hand, the run time of the naïve pattern matching algorithm increases linearly with
increasing the number of miRNAs.
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Figure 3-4: hashing-based vs naïve string matching

3.5 Discussion
Our results provide a proof of concept of the use of miRNA seed-based targeting
mechanism to predict gut bacterial genes targeted by plant miRNAs. We showed that
using our tool we can identify ginger miRNAs experimentally validated to target two
LGG genes (SpaC and LexA). Although, miRNA targeting mechanism is studied in other
species in the case of both miRNAs and target genes belong to the same species e.g.
plants and animals, to our knowledge there is no known mechanism for cross-species
miRNA targeting. Although this framework was used to predict potential mouse bacterial
genes targeted by ginger miRNAs, it can be applied to human gut bacteria and miRNAs
from any edible plant.
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In our framework, we employ a seed-based targeting technique in which we
perform an overrepresentation analysis of miRNA seed on the target sequence. This
approach was first introduced to predict miRNA targets in humans [60] and also used
with viral miRNAs [6]. we search for potential binding sites of miRNA seeds of 7 & 8
nucleotides long. This is based on previous research by Cisse et. al. [28] that suggests at
least seven Watson-Crick base pairs in the miRNA seed region are needed for rapid and
effective targeting.
We showed that our computational framework can efficiently find potential target
genes and the positions of individual binding sites in up to 8 bacterial genomes (more
than 23 million nucleotides) in less than 3 minutes. The run time is a linear function of
input size, this is because our framework utilizes hash-table and it takes O(n) to build the
index of target sequences. But once the index is built, one query takes an O(m) time,
where m is the length of the query pattern (miRNA seed in our case), and since m is a
constant (usually 7 or 8), the time complexity of one query can be O(1).
Although our proposed framework is promising, it has some limitations. Of these,
it only takes into sequence information to predict potential binding sites. Other features
like conservation, site accessibility can be utilized to increase the accuracy of our
predictions. Also, experimentally validating more targets in bacterial genes is essential to
accurately validate our framework and to infer the mechanism by which plant miRNAs
target gut bacterial genes.
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3.6 Conclusions
In this chapter, we proposed a computational framework to efficiently predict
potential bacterial genes targeted by plant miRNA. To decrease the computational
complexity of our tool, we employed a hash-table-based index to identify and count
potential miRNA binding sites. We employed a Markov chain model to quantify how
likely we see these binding sites by chance. Our tool successfully predicted ginger
miRNAs that target two experimentally validated LGG target genes. Although our tool
can be used to predict potential targeting between other plants and bacterial strains, more
wet-lab experiments are needed to infer the inter-kingdom miRNA targeting mechanism.
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4

PATHWAY ANALYSIS OF MICRORNA TARGETS IN ANIMALS

4.1 Introduction
Recent studies have suggested that microRNAs (miRNAs) are involved in many
diverse biological processes and pathways including normal development and diseases
[61]. Animal miRNAs bind to 3’UTR of mRNAs mainly through the short sequence (6-8
NTs) called seed region and act as repressors of target gene expression [62]. Taking into
account this short sequence binding, one miRNA can target hundreds or even thousands
of genes and subsequently perturb many biological pathways [38].
To computationally predict miRNA-targeted pathways, typically potential target
genes are compiled using one or more miRNA target prediction tools and a standard gene
enrichment analysis [4] is used to find potential enriched pathways or gene ontology
(GO) terms. Although the conventional pipeline is widely used, it has some limitations.
Of these, existing tools consider only direct targets (post-transcriptionally regulated) of
miRNAs but do not consider indirect targets (transcriptionally regulated) that are not
necessarily enriched in miRNA seed-binding sites [5]. Indirect target genes are mainly
regulated transcriptionally through transcription factors (TFs) [63, 64]. Furthermore, a
study suggested that TFs are preferentially targeted by miRNAs [65].
Figure 4-1 shows a scenario where a biological pathway/process can be missed by
classical miRNA pathway analysis tools. Using the classical method, the percentage of
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targeted genes is (11%), on the other hand, if we include TF targets (i.e. indirect
targets), the percentage of targeted genes will be (67%).

Figure 4-1: miRNAs can indirectly target biological pathways through transcriptions
factors
Indirectly regulated genes can be enriched in a specific biological pathway or
phenotype. One notable example is the role of miR-200 family and miR-205 in
controlling epithelial to mesenchymal transition (EMT) pathway through targeting ZEB1
and ZEB2 transcription factors [66]. Other studies have shown how miRNAs regulate cell
differentiation through targeting TFs. Of these, Tay et al [67] demonstrated the role of
miR-134 in embryonic stem cell differentiation through targeting Nanog and LRH1.
Another study showed that miR-143 and miR-145 can work together to regulate smooth
muscle cell differentiation and proliferation through targeting Klf4 and ELK1
transcription factors [68].
Several tools and web servers have been developed to predict potential biological
pathways targeted by miRNAs [69-73]. While they are all similar in terms of using direct
targets only, they use different databases for both miRNA targets and gene ontology
annotations [74-78]. miTALOS [70] is the only tool that filters potential targets by
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incorporating tissue-specific genes. All tools except for StarBase [71] accept multiple
miRNAs as input. A comprehensive comparison of widely used miRNA pathway
analysis tools is shown in Table 4-1. In this study, we introduce miRinGO (miRNA
indirect target Gene Ontology) that uncovers potential biological pathways affected by
indirect targets of human miRNAs especially ones related to cell differentiation and
development.
Table 4-1: A comparison of current tools of miRNAs pathway analysis

StarBase

mirPath v3.0

Predicted targets
databases

TargetScan
(v6) / microTCDS (v5.0)

TargetScan /
miRanda/ PITA/
RNA22/
PicTar/…

TargetScan/
miRanda

TargetScan
(v7.1) /
miRDB

Validated targets
databases

TarBase v7.0

CLIP-Seq data

CLIP-Seq data

miRTarbase

Pathways / GO
terms databases

KEGG/GO
categories

KEGG/GO/
Reactome/
BioCarta

KEGG/
WikiPathways/
Reactome

KEGG/GO/
Reactome

Inclusion of
indirect
targets?

No

No

No

No

Tissue-specific?

No

No

Yes

No

Allows multiple
miRNAs?

Yes

No

Yes

Yes
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miTALOS

miRWalk
v3.0

Features/Tools

4.2 Methods
4.2.1 Overall pipeline
Our pipeline to predict indirectly targeted biological processes by miRNAs
consists of three steps as depicted in Figure 4-2. First, for each miRNA, potential
directly-targeted TFs were compiled from the TargetScan database v7.2 [46]. Second,
computationally predicted tissue-specific TF-gene associations were collected from the
resources’ website of (Sonawane et al., 2017) [79]. In the case of multiple input miRNAs,
we use the intersection of indirect targets of each miRNA. Third, a hypergeometric test is
conducted to find potential targeted biological processes.

Figure 4-2: Pipeline of our miRNA GO enrichment analysis tool

4.2.2 Input Data
Data used by our tool was compiled from publicly available databases. Putative
miRNA targets were downloaded from TargetScan v7.2 [46]. We downloaded the file
with all predictions regardless of conservation of miRNA family or miRNA binding sites
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and kept high-confidence human miRNA targets (Cumulative weighted context++ score
< −0.1).

Computationally predicted tissue-specific TF targets were downloaded from the

resources website of (Sonawane et al., 2017) [79]. These TF targets were predicted using
the PANDA (Passing Attributes between Networks for Data Assimilation) algorithm
[80]. PANDA integrates three complimentary sources of information i.e. TF sequences
motif data, protein-protein interactions of TFs, and gene co-expression from GenotypeTissue Expression (GTEx) RNA-Seq data [81]. It contains TF-gene associations from 38
different tissues/tissue locations. We aggregated TF-gene associations from different
locations but belong to the same tissue. We had 29 broad tissues after aggregation.
Gene ontology annotations were downloaded using Ensembl Biomart [82]
(version GRCh38). GO terms with less than five genes were removed.

4.2.3 Test dataset
To validate our method, we used a ‘gold standard’ dataset of miRNAs and their
experimentally validated functions (GO terms) [83] from ftp://ftp.ebi.ac.uk/pub/databases/GO/
goa/HUMAN/goa_human_rna.gaf.

We filtered the dataset to include only high confidence

annotations (excluded annotations with “Inferred from Sequence or Structural Similarity”
(ISS), “Non-traceable Author Statement” (NAS), and “Traceable Author Statement”
(TAS) evidence codes). We also removed annotations with no reference article. To keep
only relevant annotations, we removed generic GO terms shared by most miRNAs (e.g.
“miRNA mediated inhibition of translation”, “gene silencing by miRNA” and “gene
silencing by RNA”). Cell/tissue ontology was downloaded from
http://www.ontobee.org/listTerms/CL?format=tsv

. GO terms with less than five genes were
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removed. The filtered dataset consists of 335 pairs of miRNAs and their associated GO
terms and is available in Supplementary Table S1.

4.3 Results
4.3.1 MicroRNA indirect vs direct targeting
To test the ability of our methodology to predict functions associated with a
miRNA, we used a dataset with 335 known miRNA-GO term pairs. All TargetScanpredicted targets were included in this analysis. For each miRNA-GO term pair, resulting
GO terms were ranked by the hypergeometric test p-value in ascending order, then rank
values were converted to a percentile rank by dividing by the total number of GO terms.
Finally, we picked the related GO term with the smallest p-value (smallest rank value).
Known GO terms predicted by the indirect targeting method have a significantly lower
(Wilcox signed-rank test, one-sided p-value = 0.002417) rank compared to canonical
direct targeting as shown in Figure 4-3.
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Figure 4-3: Comparison of indirect targeting with direct targeting (** represents p-value <
0.01)

4.3.2 Effect of number of miRNA targets
Since miRNA GO enrichment analysis is affected by targets of the miRNA and
TargetScan-predicted targets can have false positives, we investigated the effect of the
number of predicted miRNA targets on predicting the known GO terms. We repeated the
same analysis but instead of using all predicted targets, we used top (20%, 40%, 60%,
80% and 100%) of potential targets (sorted by TargetScan context++ score [46]). Figure
4-4 shows that in all cases, the average percentile rank of GO terms predicted by IT
methodology is lower than DT. Although increasing the number of miRNA targets
yielded a lower average rank (better performance), using all of the targets did not give
significantly better results compared to using the top 80% of targets and 40% of targets in
case of indirect and direct targeting respectively.
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Figure 4-4: Effect of the number of miRNA targets on miRNA GO enrichment analysis.
Error bars represent one standard error.

4.3.3 Indirect targeting reveals the role of miRNAs in developmental processes
To investigate biological processes that are more likely to be affected by indirect
targeting of miRNAs, we calculated TF density per GO term as defined by equation 1.
𝑇𝑇𝑇𝑇 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 =

𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 𝑜𝑜𝑜𝑜 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝑖𝑖𝑖𝑖 𝑎𝑎 𝐺𝐺𝐺𝐺 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡
𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑟𝑟 𝑜𝑜𝑜𝑜 𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔 𝑖𝑖𝑖𝑖 𝑎𝑎 𝐺𝐺𝐺𝐺 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡

Table 4-2 shows the top 5 GO BP terms with the highest TF density. All these GO
terms are related to the “developmental process” and all genes involved are transcription
factors.
Table 4-2: Top 5 GO terms with the highest TF density
GO term ID

GO term

# of TFs
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# of genes

Parent Process

(1)

GO:0001714

endodermal cell
fate
specification

5

5

GO:0003211

cardiac ventricle
formation

5

5

GO:0003357

noradrenergic
neuron
differentiation

5

5

GO:0021520

spinal cord
motor neuron
cell fate
specification

7

7

GO:0021902

commitment of
neuronal cell to
specific neuron
type in forebrain

7

7

developmental
process
developmental
process
developmental
process

developmental
process

developmental
process

To see if transcription factors are enriched in development-related GO terms
compared to other terms, we divided the GO terms (that have at least one TF) into two
groups; one with development-related terms and the second with other terms or
processes. We selected development-related terms by searching for GO biological
process terms with the following keywords ("development", "cell fate", "differentiation",
"stem cell", "morphogenesis", "cell specification", "formation"). Figure 4-5 shows that
development-related terms (n = 613) tend to have significantly (p-value < 2.2e-16,
Wilcoxon rank-sum test) higher TF density compared to other terms (n = 1767).
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Figure 4-5: Comparison of TF density in development-related GO terms vs. all other
terms

4.3.4 Case Study: role of miR-9 in Neurogenesis
To test the ability of our tool to capture relevant targeted development-related GO
terms, we picked a miRNA with a known function to be able to compare our predicted
GO terms with known ones. Of these miRNAs, miR-9 is a brain-enriched miRNA and
has a prominent role in neurogenesis [84-86]. We ran our tool with the following inputs,
we selected “brain” as the tissue type, “biological process” as the GO category, “indirect”
as the targeting mode, and “100” as the percentage of miRNA targets. Two out of the top
5 GO terms predicted are related to neurogenesis (“Nervous system development” and
“brain development”).
To compare our results with existing miRNA pathway analysis tools, we
downloaded predicted GO biological process terms for “miR-9” from 4 different web
servers (accessed January 15, 2019): mirPath v3.0 [69], StarBase (mirTarPathway
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module) v3.0 [71], miTALOS v2 [70] and miRWalk v3.0 [72]. We searched for the
highest-ranking GO term related to neurogenesis as shown in Table 4-3. Our tool ranked
neurogenesis-related GO terms higher than other tools.
Table 4-3: Comparison of highest-ranking GO terms related to neurogenesis from
different miRNA GO enrichment tools
Tool

Highest ranking GO term related to
Neurogenesis

Rank

miRinGO

Nervous system development

1

mirPath v3

regulation of neuron maturation

11

miRWalk v3

axonogenesis

13

StarBase v3

Neurogenesis

23

miTALOS v2

N/A

N/A

4.3.5 Multiple miRNAs GO analysis
In all miRNA GO analyses so far, we have used one miRNA as an input. Several
studies have shown that miRNAs can work together to regulate certain targets and
biological processes [87]. Of these, Gregory et al. [66] showed that the miR-200 family
and miR-205 together regulate epithelial to mesenchymal transition (EMT). The miR-200
family consists of miRNAs with two different seed sequences: miR-200a/miR-141 and
miR-200b/miR-200c/miR-429. We ran our tool with the following inputs: “kidney” as the
tissue type, “biological process” as the GO category, and “indirect” as the targeting mode
and “100” as the percentage of miRNA targets. The rank of “epithelial to mesenchymal
transition” GO term (GO: 0001837) was lower when we used the intersection of indirect
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targets of these three miRNAs compared to ranks of GO terms predicted by each miRNA
indirect targets as shown in Table 4-4.
Table 4-4: Effect of using multiple miRNAs in capturing EMT-related GO terms
miRNAs

Rank of top GO
term related to
EMT

miR-200a/miR-141

132

miR-200b/miR-200c/miR-429

147

miR-205-5p

105

All three miRNAs

70

4.3.6 R Shiny Application
For ease of use of our method by researchers, we developed an interactive web
application, miRinGO, using R Shiny package [7]. It is freely available from GitHub at
https://github.com/Fadeel/miRinGO.

A screenshot of the application is shown in Figure 4-6.

Figure 4-6: A screenshot of the R Shiny application (miRinGO)
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The application has two panels, the left one for input data and parameters
selection. A description of different input parameters and possible values is detailed in
Table 4-5.
Table 4-5: A description of different parameters of the Shiny application
Parameter

Description

Tissue type

29 different tissues

Brain, colon, lung, ..

input miRNAs

miRBase miRNA ID

hsa-miR-9-5p

GO category

Choose the category of GO
annotation

Targeting mode

Choose mode of miRNA
targeting

Percentage of TargetScan
target genes

percentage of top-ranked
targeted genes (sorted by
TargetScan v7.2 context++ score)

minimum number of
genes per GO term

A threshold to filter out GO
terms with small number of genes

number of GO terms for
visualization

Top k enriched GO terms to be
visualized

Possible values

Biological process OR cellular
component OR molecular function
Direct OR indirect
[20% - 100%], step size 20%
Integer value
(default value is 5)
Integer value
(default value is 10)

The right panel has two tabs for showing the results of GO enrichment analysis.
One tab named “Table of Enriched GO term” to show GO terms more likely to be
targeted by selected miRNAs and ranked by the hypergeometric p-value. The table
includes information about GO term, number of genes in that term, number of potential
miRNA targets that overlap with genes in this term, hypergeometric p-value, and the
Benjamini & Hochberg [57] adjusted p-value. To get more details about a specific GO
term, GO term accession numbers are linked to their QuickGO [88] webpages.
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The other tab named “visualization” provides a visual summary of the enriched
GO term. It contains a bar plot with bar height represents the -log10(adjusted p-value)
and bar color represents the proportion of potential target genes out of the total number of
genes in that GO term. Bar plot of top 15 GO terms indirectly targeted by miR-9-5p in
the brain is shown in Figure 4-7.

Figure 4-7: Bar plot of top 15 GO terms indirectly targeted by miR-9-5p in brain
miRinGO also provides a visual summary of the top enriched GO terms as
WordCloud. To generate the WordCloud, we need to find high-frequency words. First,
top enriched GO terms are preprocessed to remove punctuation, numbers, English stop
words, and common biological terms (process, cell, miRNA). We used “tm” R package
[89] for text preprocessing steps. A snapshot of the WordCloud of top 30 enriched GO
terms predicted to be indirectly targeted by miR-16 in the colon is shown in Figure 4-8.
We can see that words like mitotic, cycle, segregation, and division are related to cell

52

cycle. Linsley et. al, had previously shown that overexpression of miR-16 family in
HCT116 (human colorectal carcinoma) cell lines regulates cell cycle progression [5].

Figure 4-8: WordCloud of top 30 enriched GO terms predicted to be indirectly targeted
by miR-16 in the colon

4.4 Discussion
We propose, miRinGO, a tool that detects biological processes indirectly targeted
by miRNAs transcriptionally through transcription factors. Using miRinGO, we can
include potential target genes even if there is no physical interaction between miRNA and
the regulated genes. To validate this method, we used a dataset of miRNAs and their
known targeted GO terms [83]. Although this dataset is considered a significant step
towards having a gold standard to validate different miRNA pathway or GO analysis
tools, it is still limited to a fraction of human miRNAs and focused more on
cardiovascular-related processes. Using this dataset, however, indirect targeting showed
better performance in predicting known targeted processes compared to the direct
targeting method, even if we use different fractions of input miRNA targets. It is also
worth noting that although increasing the number of miRNA targets yielded better
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performance, using all of the targets did not give significantly better results compared to
using the top 80% of targets and 40% of targets in case of indirect and direct targeting,
respectively. This could be because miRNA target prediction tools suffer from having
many false positives [90].
Since our method is mainly focused on miRNA-targeted TFs and developmentrelated GO terms or pathways have more TFs than other terms, it is more suitable to use
this tool to uncover the tissue-specific roles of miRNAs in development and cell
differentiation. Using this method, we predicted biological pathways known to be
targeted by miR-9, a miRNA with a known role in neurogenesis. Tan et al. [91] showed
that miR-9 regulates neural stem cell differentiation and proliferation by targeting HES1
transcription factor. Using indirect targeting, three genes related to neuron differentiation
(FEZF2, SOX3, and ZHX2) that are predicted to be targeted by HES1 (but are not direct
targets of miR-9-5p) are now included in GO enrichment analysis as indirect targets of
miR-9-5p.
One limitation of our method is that we use two sets of computationally predicted
targets: one for miRNA direct targets and the other for tissue-specific TF targets. This
might increase the effect of false positives in miRNA GO enrichment analysis. This
limitation can be partly alleviated by using only high-confidence miRNA targets (i.e.
ones with smaller TargetScan context++ score). Although our method outperformed the
current miRNA GO analysis method, it is not intended to replace the standard miRNA
GO analysis method but on the other hand, to give a different perspective of miRNA
roles in regulating biological processes and to uncover ones that are previously
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overlooked by current tools, especially ones related to development and cell
differentiation.

4.5 Conclusions
Although miRNAs have emerged as important players in gene regulation, the
field still lacks computational tools and methods that can predict their functions
accurately. We propose a method to predict biological processes that are indirectly
targeted by miRNAs transcriptionally through transcription factors. The proposed method
provided better performance compared to the existing method. We also developed an
interactive web application to make it easier for researchers to investigate the function of
miRNA(s) of choice.
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5

SUMMARY AND FUTURE WORK

Given the recent advances in DNA/RNA sequencing, new genes/transcripts are
being discovered and the need to assign functions to these genes grows. Of these genes,
miRNAs are non-protein-coding genes and act as regulators of gene expression of other
genes. Recent studies have suggested that miRNAs have a role in many biological
processes e.g., cell cycle, proliferation, and development. Moreover, miRNAs may
function as tumor suppressors and oncogene. Current experimental techniques for
discovering miRNA target genes are either low throughput, costly, or suffer from high
false-positive rates. For the above reasons, computational tools are needed to predict
targeted genes and ultimately targeted biological processes.
In the first part of this dissertation, we developed a tool to predict gut bacterial
genes potentially targeted by miRNAs from edible plants like ginger. To our knowledge,
it is the only known tool dedicated to inter-kingdom miRNA targeting. Although we were
able to correctly predict ginger miRNAs targeting two bacterial genes, there is still a need
in the future for more experimentally validated targets to get a better idea regarding interkingdom targeting mechanisms.
Although this tool can find potential target genes of 49 miRNAs in eight different
bacterial genomes in less than three minutes, there is still room to improve the scalability
of this tool in the future. For instance, we use an integer representation of miRNA seed
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sequences (8 nucleotides) which requires 28 bytes in Python 3. This can be
reduced by taking advantage of the fact that DNA/RNA sequences have 4 letters, and
each nucleotide can be represented by 2 bits. Using this representation, miRNA seed
regions can be represented as a vector of 16 bits (2 bytes).
In the second part, we addressed the problem of functional annotation of human
miRNAs. Current tools consider only target genes with binding sites. To address this
limitation, we developed miRinGO, an R Shiny web application that allows researchers to
include other indirect target genes e.g., genes regulated through transcription factors.
Indirect targeting showed better performance compared to direct targeting in predicting
known miRNA-biological process associations. miRinGO provides an easy-to-use GUI
for researchers with no coding experience to explore potential functions of over 2,000
miRNAs in 38 tissues. Moreover, it provides visual summaries of the results. miRinGO is
available at https://github.com/Fadeel/miRinGO. Potential future work includes
supporting miRNAs from other species e.g. mouse and giving the user the ability to filter
target genes based on the existing experimental evidence.
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APPENDIX I
miRNA ID

mature sequence

gma-miR319a

TTGGACTGAAGGGAGCTCCC

aly-miR319a-3p

TTGGACTGAAGGGAGCTCCCT

ppt-miR319a

CTTGGACTGAAGGGAGCTCC

ppt-miR319c

CTTGGACTGAAGGGAGCTCCC

aly-miR396a-5p

TTCCACAGCTTTCTTGAACTG

gma-miR396e

TTCCACAGCTTTCTTGAACTGT

gma-miR396h

TCCACAGCTTTCTTGAACTG

ptc-miR319e

TTGGACTGAAGGGAGCTCCT

aly-miR159a-3p

TTTGGATTGAAGGGAGCTCTA

mtr-miR319c-3p

TTGGACTGAAGGGAGCTCCCA

aly-miR166a-3p

TCGGACCAGGCTTCATTCCCC

gma-miR166p

TCGGACCAGGCTTCATTCCC

bdi-miR166f

TCTCGGACCAGGCTTCATTCC

gma-miR166m

CGGACCAGGCTTCATTCCCC

gma-miR166u

TCTCGGACCAGGCTTCATTC

bdi-miR166e-3p

CTCGGACCAGGCTTCATTCCC

gma-miR319p

TTTTGGACTGAAGGGAGCTCC

64

aly-miR396b-5p

TTCCACAGCTTTCTTGAACTT

miRNA ID

mature sequence

gma-miR6300

GTCGTTGTAGTATAGTGG

sbi-miR166k

TCGGACCAGGCTTCATTCCT

osa-miR396d

TCCACAGGCTTTCTTGAACGG

aly-miR168a-5p

TCGCTTGGTGCAGGTCGGGAA

gma-miR168b

TCGCTTGGTGCAGGTCGGG

aly-miR162a-3p

TCGATAAACCTCTGCATCCAG

gma-miR162a

TCGATAAACCTCTGCATCCA

aly-miR858-5p

TTTCGTTGTCTGTTCGACCTT

ath-miR858b

TTCGTTGTCTGTTCGACCTTG

zma-miR396g-3p

GTTCAAGAAAGCTGTGGAAGA

gma-miR4995

AGGCAGTGGCTTGGTTAAGGG

mtr-miR166c

TCGGACCAGGCTTCATTCCTC

aly-miR156a-5p

TGACAGAAGAGAGTGAGCAC

aly-miR396a-3p

GTTCAATAAAGCTGTGGGAAG

ath-miR156j

TGACAGAAGAGAGAGAGCAC

bdi-miR156a

TGACAGAAGAGAGAGAGCACA

gma-miR156f

TTGACAGAAGAGAGAGAGCACA

gma-miR396a-3p

TTCAATAAAGCTGTGGGAAG
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miRNA ID

mature sequence

mdm-miR156t

TTGACAGAAGAGAGAGAGCAC

mdm-miR535a

TGACAACGAGAGAGAGCACGC

osa-miR396a-3p

GTTCAATAAAGCTGTGGGAA

ptc-miR156k

TGACAGAAGAGAGGGAGCAC

stu-miR156f-5p

CTGACAGAAGAGAGTGAGCA

aly-miR167a-5p

TGAAGCTGCCAGCATGATCTA

aly-miR167d-5p

TGAAGCTGCCAGCATGATCTGG

bdi-miR398a

TGTGTTCTCAGGTCGCCCCTG

gma-miR167c

TGAAGCTGCCAGCATGATCTG

aly-miR157a-5p

TTGACAGAAGATAGAGAGCAC

aly-miR157d-5p

TGACAGAAGATAGAGAGCAC

aly-miR164a-5p

TGGAGAAGCAGGGCACGTGCA

aly-miR166a-5p

GGAATGTTGTCTGGCTCGAGG
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APPENDIX II
miRNA

GO term name

GO ID

reference

Cell IDs

Cell types

artery

hsa-let-7b-5p

GO:0045766

PMID:28159509

CL:0000071

blood vessel endothelial cell

artery

hsa-let-7e-5p

GO:0043433

PMID:30670152

CL:0002618

endothelial cell of umbilical vein

artery

hsa-let-7e-5p

GO:0042532

PMID:30670152

CL:0002618

endothelial cell of umbilical vein

artery

hsa-let-7f-5p

GO:0030512

PMID:28345812

CL:0002618

endothelial cell of umbilical vein

artery

hsa-let-7g-5p

GO:0050728

PMID:24291274

CL:0002618

endothelial cell of umbilical vein

artery

hsa-let-7g-5p

GO:0060394

PMID:24291274

CL:0002618

endothelial cell of umbilical vein

artery

hsa-let-7g-5p

GO:0030512

PMID:24291274

CL:0002618

endothelial cell of umbilical vein

artery

hsa-let-7g-5p

GO:0045766

PMID:24291274

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-1-3p

GO:1905461

PMID:26166810

CL:0002539

aortic smooth muscle cell

artery
artery

hsa-miR-101-3p
hsa-miR-106b-5p

GO:0031397
GO:0016525

PMID:24844779
PMID:26956882

CL:0002618
CL:0000071

endothelial cell of umbilical vein
blood vessel endothelial cell

artery

hsa-miR-10a-5p

GO:1903589

PMID:22955733

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-10a-5p

GO:0090050

PMID:22955733

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-10a-5p

GO:0030949

PMID:22955733

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-10b-5p

GO:1903589

PMID:22955733

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-10b-5p

positive regulation of angiogenesis
negative regulation of DNA-binding transcription
factor activity
negative regulation of tyrosine phosphorylation
of STAT protein
negative regulation of transforming growth
factor beta receptor signaling pathway
negative regulation of inflammatory response
negative regulation of pathway-restricted SMAD
protein phosphorylation
negative regulation of transforming growth
factor beta receptor signaling pathway
positive regulation of angiogenesis
positive regulation of vascular associated
smooth muscle cell apoptotic process
negative regulation of protein ubiquitination
negative regulation of angiogenesis
positive regulation of blood vessel endothelial
cell proliferation involved in sprouting
angiogenesis
positive regulation of cell migration involved in
sprouting angiogenesis
positive regulation of vascular endothelial
growth factor receptor signaling pathway
positive regulation of blood vessel endothelial
cell proliferation involved in sprouting
angiogenesis
positive regulation of cell migration involved in
sprouting angiogenesis

GO:0090050

PMID:22955733

CL:0002618

endothelial cell of umbilical vein
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Tissue name
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artery

hsa-miR-10b-5p

artery
artery

hsa-miR-1224-5p
hsa-miR-1224-5p

artery

hsa-miR-1224-5p

artery

hsa-miR-124-3p

artery

hsa-miR-124-3p

artery

hsa-miR-125a-5p

artery

hsa-miR-125a-5p

artery

hsa-miR-125a-5p

artery

hsa-miR-125a-5p

artery
artery
artery
artery
artery

hsa-miR-125a-5p
hsa-miR-125b-5p
hsa-miR-126-3p
hsa-miR-126-3p
hsa-miR-126-3p

artery

hsa-miR-126-3p

artery

positive regulation of vascular endothelial
growth factor receptor signaling pathway
negative regulation of Notch signaling pathway
positive regulation of sprouting angiogenesis
positive regulation of vascular endothelial
growth factor receptor signaling pathway

GO:0030949

PMID:22955733

CL:0002618

endothelial cell of umbilical vein

GO:0045746
GO:1903672

PMID:28717225
PMID:28717225

CL:0002618
CL:0002618

endothelial cell of umbilical vein
endothelial cell of umbilical vein

GO:0030949

PMID:28717225

CL:0002618

endothelial cell of umbilical vein

cellular response to hypoxia

GO:0071456

PMID:23853098

CL:0002591

GO:0035308

PMID:23853098

CL:0002591

GO:0016525

PMID:25116893

CL:0002618

smooth muscle cell of the
pulmonary artery
smooth muscle cell of the
pulmonary artery
endothelial cell of umbilical vein

GO:0043433

PMID:30670152

CL:0002618

endothelial cell of umbilical vein

GO:0042532

PMID:30670152

CL:0002618

endothelial cell of umbilical vein

GO:1903672
GO:0016525
GO:0071456
GO:0050728
GO:0045766

PMID:25116893
,PMID:2846751
4
PMID:27252357
PMID:22391569
PMID:28578351
PMID:28578351
PMID:23136161

CL:0002618
,CL:000261
8
CL:0002618
CL:0002618
CL:2000008
CL:2000008
CL:0002544

endothelial cell of umbilical
vein,endothelial cell of umbilical
vein
endothelial cell of umbilical vein
endothelial cell of umbilical vein
microvascular endothelial cell
microvascular endothelial cell
aortic endothelial cell

negative regulation of protein
dephosphorylation
negative regulation of angiogenesis
negative regulation of DNA-binding transcription
factor activity
negative regulation of tyrosine phosphorylation
of STAT protein
positive regulation of endothelial cell apoptotic
process

GO:2000353

GO:0014068

PMID:28578351

CL:2000008

microvascular endothelial cell

hsa-miR-126-3p

positive regulation of sprouting angiogenesis
negative regulation of angiogenesis
cellular response to hypoxia
negative regulation of inflammatory response
positive regulation of angiogenesis
positive regulation of phosphatidylinositol 3kinase signaling
positive regulation of protein kinase B signaling

GO:0051897

artery

hsa-miR-126-3p

positive regulation of sprouting angiogenesis

GO:1903672

CL:2000008
CL:0002618
,CL:200000
8

microvascular endothelial cell
endothelial cell of umbilical
vein,microvascular endothelial
cell

artery

hsa-miR-126-5p

positive regulation of blood vessel endothelial
cell proliferation involved in sprouting
angiogenesis

PMID:28578351
PMID:27780851
,PMID:2857835
1

GO:1903589

PMID:28124060

CL:0002618

endothelial cell of umbilical vein
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artery

hsa-miR-126-5p

artery

hsa-miR-130a-3p

artery

hsa-miR-130a-3p

artery

hsa-miR-130a-3p

artery
artery
artery
artery

hsa-miR-132-3p
hsa-miR-132-3p
hsa-miR-132-5p
hsa-miR-132-5p

artery

hsa-miR-132-5p

artery

hsa-miR-133a-3p

artery

hsa-miR-133a-3p

artery

hsa-miR-138-5p

artery

hsa-miR-138-5p

artery

hsa-miR-138-5p

artery

positive regulation of cell migration involved in
sprouting angiogenesis
positive regulation of angiogenesis
positive regulation of vascular endothelial cell
proliferation
positive regulation of vascular smooth muscle
cell proliferation
positive regulation of angiogenesis
positive regulation of protein kinase B signaling
cholesterol homeostasis
fatty acid homeostasis
positive regulation of endothelial cell apoptotic
process

GO:0090050

PMID:28124060

CL:0002618

endothelial cell of umbilical vein

GO:0045766

PMID:23136161

aortic endothelial cell

GO:1905564

PMID:24960162

GO:1904707

PMID:24960162

GO:0045766
GO:0051897
GO:0042632
GO:0055089

PMID:21868695
PMID:21868695
PMID:24924687
PMID:24924687

CL:0002544
UBERON:0
002012
UBERON:0
002012
CL:0000071
CL:0000071
CL:0002618
CL:0002618

blood vessel endothelial cell
blood vessel endothelial cell
endothelial cell of umbilical vein
endothelial cell of umbilical vein

GO:2000353

PMID:24924687

CL:0002618

endothelial cell of umbilical vein

GO:0071345

PMID:28257760

CL:0000359

GO:0010989

PMID:28257760

CL:0000359

GO:2000134

PMID:28450935

CL:0002546

GO:0051001

PMID:24244340

CL:2000008

negative regulation of p38MAPK cascade

GO:1903753

PMID:28450935

CL:0002546

hsa-miR-138-5p

negative regulation of sprouting angiogenesis

GO:1903671

PMID:24244340

CL:2000008

artery

hsa-miR-140-5p

cellular response to hypoxia

GO:0071456

PMID:27021683

CL:0002591

artery

hsa-miR-140-5p

positive regulation of BMP signaling pathway

GO:0030513

PMID:27214554

CL:0002591

artery

hsa-miR-140-5p

GO:1905461

PMID:27021683

CL:0002591

artery

hsa-miR-143-3p

positive regulation of vascular associated
smooth muscle cell apoptotic process
negative regulation of angiogenesis

GO:0016525

PMID:25801897

CL:0002618

artery

hsa-miR-143-3p

positive regulation of angiogenesis

GO:0045766

PMID:26311719

CL:1001568

cellular response to cytokine stimulus
negative regulation of low-density lipoprotein
particle clearance
negative regulation of G1/S transition of mitotic
cell cycle
negative regulation of nitric-oxide synthase
activity

pulmonary artery
pulmonary artery

vascular associated smooth
muscle cell
vascular associated smooth
muscle cell
embryonic blood vessel
endothelial progenitor cell
microvascular endothelial cell
embryonic blood vessel
endothelial progenitor cell
microvascular endothelial cell
smooth muscle cell of the
pulmonary artery
smooth muscle cell of the
pulmonary artery
smooth muscle cell of the
pulmonary artery
endothelial cell of umbilical vein
pulmonary artery endothelial
cell
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artery

hsa-miR-145-5p

negative regulation of angiogenesis

GO:0016525

PMID:25801897

CL:0002618

endothelial cell of umbilical vein
brain microvascular endothelial
cell
retinal blood vessel endothelial
cell
endothelial cell of umbilical vein
retinal blood vessel endothelial
cell
brain microvascular endothelial
cell
retinal blood vessel endothelial
cell

artery

hsa-miR-146a-5p

cellular response to cytokine stimulus

GO:0071345

PMID:25515214

CL:2000044

artery

hsa-miR-146a-5p

cellular response to glucose stimulus

GO:0071333

PMID:28433754

CL:0002585

artery

hsa-miR-146a-5p

negative regulation of angiogenesis

GO:0016525

PMID:23619365

CL:0002618

artery

hsa-miR-146a-5p

negative regulation of interleukin-6 production

GO:0032715

PMID:28433754

CL:0002585

artery

hsa-miR-146a-5p

negative regulation of NIK/NF-kappaB signaling

GO:1901223

PMID:25515214

CL:2000044

artery

hsa-miR-146a-5p

GO:0042532

PMID:28433754

CL:0002585

artery

hsa-miR-146a-5p

GO:0045743

PMID:27121396

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-149-3p

GO:0040037

PMID:24463821

CL:0002544

aortic endothelial cell

artery

hsa-miR-149-5p

GO:0040037

PMID:24463821

CL:0002544

aortic endothelial cell

artery

hsa-miR-149-5p

GO:0032715

PMID:24299952

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-152-3p

artery
artery

GO:0010804

PMID:24813629

CL:0002618

endothelial cell of umbilical vein

hsa-miR-155-5p
hsa-miR-155-5p

negative regulation of tyrosine phosphorylation
of STAT protein
positive regulation of fibroblast growth factor
receptor signaling pathway
negative regulation of fibroblast growth factor
receptor signaling pathway
negative regulation of fibroblast growth factor
receptor signaling pathway
negative regulation of interleukin-6 production
negative regulation of tumor necrosis factormediated signaling pathway
negative regulation of inflammatory response
positive regulation of sprouting angiogenesis

GO:0050728
GO:1903672

PMID:21310411
PMID:27731397

CL:0000071
CL:0002618

artery

hsa-miR-15a-5p

cellular response to glucose stimulus

GO:0071333

PMID:30365148

CL:0002585

artery

hsa-miR-15a-5p

GO:0016525

PMID:23867820

CL:0002618

artery

hsa-miR-15a-5p

GO:0090051

PMID:22692216

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-15a-5p

negative regulation of angiogenesis
negative regulation of cell migration involved in
sprouting angiogenesis
negative regulation of G1/S transition of mitotic
cell cycle

blood vessel endothelial cell
endothelial cell of umbilical vein
retinal blood vessel endothelial
cell
endothelial cell of umbilical vein

GO:2000134

PMID:23867820

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-15a-5p

negative regulation of inflammatory response

GO:0050728

PMID:30365148

CL:0002585

artery

hsa-miR-15a-5p

negative regulation of NF-kappaB transcription
factor activity

GO:0032088

PMID:30365148

CL:0002585

retinal blood vessel endothelial
cell
retinal blood vessel endothelial
cell

artery

hsa-miR-15b-5p

artery

hsa-miR-15b-5p

artery

hsa-miR-16-5p

artery

hsa-miR-16-5p

artery

branching involved in blood vessel
morphogenesis
negative regulation of angiogenesis
branching involved in blood vessel
morphogenesis

UBERON:0
007777
CL:0002618
UBERON:0
007777
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GO:0001569

PMID:23688497

GO:0016525

PMID:27208409

GO:0001569

PMID:23083510

cellular response to glucose stimulus

GO:0071333

PMID:30365148

CL:0002585

hsa-miR-16-5p

negative regulation of fibroblast growth factor
receptor signaling pathway

retinal blood vessel endothelial
cell

GO:0040037

PMID:21885851

CL:0002544

aortic endothelial cell

artery

hsa-miR-16-5p

negative regulation of inflammatory response

GO:0050728

PMID:30365148

CL:0002585

artery

hsa-miR-16-5p

GO:0032088

PMID:30365148

CL:0002585

artery

hsa-miR-16-5p

GO:1900747

PMID:21885851

CL:0002544

aortic endothelial cell

artery

hsa-miR-17-5p

GO:0071456

PMID:27640178

CL:0002591

artery

hsa-miR-17-5p

GO:1904707

PMID:22161164

artery
artery

hsa-miR-185-3p
hsa-miR-185-5p

GO:0070373
GO:0016525

PMID:28277742
PMID:26694763

UBERON:0
002012
CL:0002539
CL:2000008

smooth muscle cell of the
pulmonary artery

artery

hsa-miR-193a-3p

GO:2000134

PMID:28276476

CL:0002546

artery

hsa-miR-196a-5p

GO:0035924

PMID:22773844

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-196a-5p

GO:0090051

PMID:22773844

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-19b-3p

GO:0090051

PMID:22197821

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-19b-3p

GO:0010972

PMID:22197821

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-19b-3p

GO:1900004

PMID:24998411

CL:0002618

endothelial cell of umbilical vein

negative regulation of NF-kappaB transcription
factor activity
negative regulation of vascular endothelial
growth factor signaling pathway
cellular response to hypoxia
positive regulation of vascular smooth muscle
cell proliferation
negative regulation of ERK1 and ERK2 cascade
negative regulation of angiogenesis
negative regulation of G1/S transition of mitotic
cell cycle
cellular response to vascular endothelial growth
factor stimulus
negative regulation of cell migration involved in
sprouting angiogenesis
negative regulation of cell migration involved in
sprouting angiogenesis
negative regulation of G2/M transition of mitotic
cell cycle
negative regulation of serine-type
endopeptidase activity

umbilical vein endothelium
endothelial cell of umbilical vein
umbilical vein endothelium

retinal blood vessel endothelial
cell
retinal blood vessel endothelial
cell

pulmonary artery
aortic smooth muscle cell
microvascular endothelial cell
embryonic blood vessel
endothelial progenitor cell
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artery

hsa-miR-200a-3p

artery

hsa-miR-200b-3p

artery

hsa-miR-200b-3p

artery

hsa-miR-20a-5p

artery

hsa-miR-20a-5p

artery

hsa-miR-20a-5p

artery

hsa-miR-20a-5p

artery

hsa-miR-20a-5p

artery
artery
artery

hsa-miR-20b-5p
hsa-miR-20b-5p
hsa-miR-20b-5p

artery

hsa-miR-21-3p

artery

hsa-miR-21-5p

artery

positive regulation of blood vessel endothelial
cell migration
negative regulation of angiogenesis
negative regulation of blood vessel endothelial
cell migration
cellular response to vascular endothelial growth
factor stimulus
negative regulation of cell migration involved in
sprouting angiogenesis

GO:0043536

PMID:21698760

CL:0002618

endothelial cell of umbilical vein

GO:0016525

PMID:21081489

CL:2000008

microvascular endothelial cell

GO:0043537

PMID:21081489

CL:2000008

microvascular endothelial cell

GO:0035924

PMID:22696064

CL:0002618

endothelial cell of umbilical vein

GO:0090051

PMID:22696064

CL:0002618

endothelial cell of umbilical vein

negative regulation of protein kinase activity

GO:0006469

PMID:25447536

CL:0002591

positive regulation of angiogenesis
positive regulation of vascular smooth muscle
cell proliferation
cellular response to tumor necrosis factor
negative regulation of angiogenesis
positive regulation of cellular senescence
negative regulation of NF-kappaB transcription
factor activity

GO:0045766

PMID:28097093

CL:0002618

GO:1904707

PMID:22450430

CL:0002591

GO:0071356
GO:0016525
GO:2000774

PMID:28595801
PMID:24048733
PMID:28595801

CL:2000008
CL:0002618
CL:2000008

smooth muscle cell of the
pulmonary artery
endothelial cell of umbilical vein
smooth muscle cell of the
pulmonary artery
microvascular endothelial cell
endothelial cell of umbilical vein
microvascular endothelial cell

GO:0032088

PMID:25327529

CL:0002544

aortic endothelial cell

BMP signaling pathway

GO:0030509

PMID:18548003

hsa-miR-21-5p

cellular response to lipopolysaccharide

GO:0071222

PMID:29039542

UBERON:0
002012
CL:0002618

artery

hsa-miR-21-5p

negative regulation of GTPase activity

GO:0034260

PMID:22158624

CL:0000359

artery

hsa-miR-21-5p

GO:0045766

PMID:27708252

CL:2000008

artery

hsa-miR-21-5p

GO:1903589

PMID:30106099

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-21-5p

positive regulation of angiogenesis
positive regulation of blood vessel endothelial
cell proliferation involved in sprouting
angiogenesis
positive regulation of inflammatory response

endothelial cell of umbilical vein
vascular associated smooth
muscle cell
microvascular endothelial cell

GO:0050729

CL:0000071

blood vessel endothelial cell

artery

hsa-miR-21-5p

PMID:21636785
PMID:20693317
,PMID:2069331
7,PMID:218171
07

UBERON:0
002012,UB
ERON:0002

pulmonary artery,pulmonary
artery,femoral artery

positive regulation of vascular associated
smooth muscle cell migration

GO:1904754

pulmonary artery

hsa-miR-21-5p

positive regulation of vascular endothelial
growth factor signaling pathway

artery

artery

012,UBERO
N:0002060
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GO:1900748

PMID:30106099

CL:0002618

endothelial cell of umbilical vein

hsa-miR-21-5p

positive regulation of vascular smooth muscle
cell proliferation

GO:1904707

PMID:20693317
,PMID:2181710
7

UBERON:0
002012,UB
ERON:0002
060

pulmonary artery,femoral artery

artery

hsa-miR-21-5p

regulation of cell shape

GO:0008360

PMID:21817107

CL:0000359

artery
artery
artery
artery
artery

hsa-miR-210-3p
hsa-miR-210-3p
hsa-miR-210-3p
hsa-miR-212-3p
hsa-miR-212-3p

positive regulation of angiogenesis
positive regulation of cell migration
tube formation
negative regulation of angiogenesis
positive regulation of Notch signaling pathway

GO:0045766
GO:0030335
GO:0035148
GO:0016525
GO:0045747

PMID:18417479
PMID:23322395
PMID:23322395
PMID:25217442
PMID:25217442

CL:0002618
CL:2000008
CL:2000008
CL:0002618
CL:0000071

artery

hsa-miR-214-3p

cellular response to hypoxia

GO:0071456

PMID:27144530

CL:0002591

artery
artery

hsa-miR-214-3p
hsa-miR-214-3p

GO:0030336
GO:0008285

PMID:25656649
PMID:25656649

artery

hsa-miR-214-3p

GO:1904753

PMID:27927633

artery

hsa-miR-214-3p

GO:1904706

PMID:27927633

CL:0002618
CL:0002618
UBERON:0
000947
UBERON:0
000947

artery

hsa-miR-214-3p

GO:1900087

PMID:27144530

artery

hsa-miR-214-5p

GO:1904707

PMID:28684904

artery
artery
artery
artery

hsa-miR-218-5p
hsa-miR-22-3p
hsa-miR-221-3p
hsa-miR-221-3p

GO:0043407
GO:0050729
GO:0050728
GO:1903671

PMID:21385766
PMID:28112401
PMID:21310411
PMID:27780851

UBERON:0
002012
CL:0000071
CL:0002618
CL:0000071
CL:0002618

artery

hsa-miR-221-3p

negative regulation of cell migration
negative regulation of cell proliferation
negative regulation of vascular associated
smooth muscle cell migration
negative regulation of vascular smooth muscle
cell proliferation
positive regulation of G1/S transition of mitotic
cell cycle
positive regulation of vascular smooth muscle
cell proliferation
negative regulation of MAP kinase activity
positive regulation of inflammatory response
negative regulation of inflammatory response
negative regulation of sprouting angiogenesis
platelet-derived growth factor receptor signaling
pathway

GO:0048008

PMID:19088079

CL:0002591

CL:0002591

vascular associated smooth
muscle cell
endothelial cell of umbilical vein
microvascular endothelial cell
microvascular endothelial cell
endothelial cell of umbilical vein
blood vessel endothelial cell
smooth muscle cell of the
pulmonary artery
endothelial cell of umbilical vein
endothelial cell of umbilical vein
aorta
aorta
smooth muscle cell of the
pulmonary artery
pulmonary artery
blood vessel endothelial cell
endothelial cell of umbilical vein
blood vessel endothelial cell
endothelial cell of umbilical vein
smooth muscle cell of the
pulmonary artery
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artery

hsa-miR-221-3p

artery

hsa-miR-222-3p

positive regulation of blood vessel endothelial
cell migration
negative regulation of inflammatory response

artery

hsa-miR-223-3p

negative regulation of GTPase activity

artery

hsa-miR-23a-3p

artery

hsa-miR-23a-3p

artery

hsa-miR-23a-3p

artery

hsa-miR-23a-3p

artery

hsa-miR-23a-3p

artery

hsa-miR-23b-3p

artery

hsa-miR-23b-3p

artery

hsa-miR-23b-3p

artery

hsa-miR-23b-3p

artery
artery
artery

hsa-miR-23b-3p
hsa-miR-23b-3p
hsa-miR-24-3p

artery

hsa-miR-24-3p

artery

hsa-miR-24-3p

artery

hsa-miR-24-3p

artery

hsa-miR-26a-5p

cellular response to vascular endothelial growth
factor stimulus
negative regulation of vascular permeability
positive regulation of blood vessel endothelial
cell proliferation involved in sprouting
angiogenesis
positive regulation of cell migration involved in
sprouting angiogenesis
positive regulation of ERK1 and ERK2 cascade
cellular response to vascular endothelial growth
factor stimulus
negative regulation of sprouting angiogenesis
positive regulation of blood vessel endothelial
cell proliferation involved in sprouting
angiogenesis
positive regulation of cell migration involved in
sprouting angiogenesis
positive regulation of ERK1 and ERK2 cascade
positive regulation of vascular permeability
negative regulation of angiogenesis
positive regulation of endothelial cell apoptotic
process
positive regulation of reactive oxygen species
biosynthetic process
positive regulation of vascular associated
smooth muscle cell apoptotic process
negative regulation of BMP signaling pathway

GO:0043536

PMID:19351599

CL:0002618

endothelial cell of umbilical vein

GO:0050728

PMID:21310411

CL:0000071

GO:0034260

PMID:27121304

CL:0002591

blood vessel endothelial cell
smooth muscle cell of the
pulmonary artery

GO:0035924

PMID:21536891

CL:0002618

endothelial cell of umbilical vein

GO:0043116

PMID:27741223

CL:0002618

endothelial cell of umbilical vein

GO:1903589

PMID:21536891

CL:0002618

endothelial cell of umbilical vein

GO:0090050

PMID:21536891

CL:0002618

endothelial cell of umbilical vein

GO:0070374

PMID:21536891

CL:0002618

endothelial cell of umbilical vein

GO:0035924

PMID:21536891

CL:0002618

endothelial cell of umbilical vein

GO:1903671

PMID:27741223

CL:0002618

endothelial cell of umbilical vein

GO:1903589

PMID:21536891

CL:0002618

endothelial cell of umbilical vein

GO:0090050

PMID:21536891

CL:0002618

endothelial cell of umbilical vein

GO:0070374
GO:0043117
GO:0016525

PMID:21536891
PMID:27741223
PMID:23774796

CL:0002618
CL:0002618
CL:2000008

endothelial cell of umbilical vein
endothelial cell of umbilical vein
microvascular endothelial cell

GO:2000353

PMID:21788589

CL:0000071

blood vessel endothelial cell

GO:1903428

PMID:21788589

CL:0000071

blood vessel endothelial cell

GO:1905461

PMID:23774796

CL:2000008

microvascular endothelial cell

GO:0030514

PMID:24047927

CL:0002618

endothelial cell of umbilical vein

hsa-miR-26a-5p

artery

hsa-miR-26a-5p

artery

hsa-miR-26a-5p

artery

hsa-miR-26a-5p

artery

hsa-miR-26a-5p

artery

hsa-miR-26a-5p

artery

hsa-miR-27a-3p

artery

hsa-miR-27a-3p

artery

hsa-miR-27a-3p

artery

hsa-miR-27a-3p

artery

hsa-miR-27a-5p

artery

hsa-miR-27b-3p

artery

hsa-miR-27b-3p

artery

hsa-miR-27b-3p

artery

hsa-miR-27b-3p

artery

hsa-miR-296-5p

artery

hsa-miR-296-5p
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artery

negative regulation of cell migration involved in
sprouting angiogenesis
negative regulation of DNA-binding transcription
factor activity
negative regulation of G1/S transition of mitotic
cell cycle
negative regulation of nitric-oxide synthase
activity
transforming growth factor beta receptor
signaling pathway
vascular endothelial growth factor signaling
pathway
cellular response to vascular endothelial growth
factor stimulus
positive regulation of blood vessel endothelial
cell proliferation involved in sprouting
angiogenesis
positive regulation of cell migration involved in
sprouting angiogenesis
positive regulation of ERK1 and ERK2 cascade
negative regulation of NF-kappaB transcription
factor activity
cellular response to vascular endothelial growth
factor stimulus
positive regulation of blood vessel endothelial
cell proliferation involved in sprouting
angiogenesis
positive regulation of cell migration involved in
sprouting angiogenesis
positive regulation of ERK1 and ERK2 cascade
positive regulation of cell migration involved in
sprouting angiogenesis
positive regulation of vascular endothelial
growth factor receptor signaling pathway

GO:0090051

PMID:24047927
,PMID:2860216
2

CL:0002618
,CL:000261
8

endothelial cell of umbilical
vein,endothelial cell of umbilical
vein

GO:0043433

PMID:24047927

CL:0002618

endothelial cell of umbilical vein

GO:2000134

PMID:24047927

CL:0002618

endothelial cell of umbilical vein

GO:0051001

PMID:28602162

CL:0002618

endothelial cell of umbilical vein

GO:0007179

PMID:20857419

CL:0002539

aortic smooth muscle cell

GO:0038084

PMID:28602162

CL:0002618

endothelial cell of umbilical vein

GO:0035924

PMID:21536891

CL:0002618

endothelial cell of umbilical vein

GO:1903589

PMID:21536891

CL:0002618

endothelial cell of umbilical vein

GO:0090050

PMID:21536891

CL:0002618

endothelial cell of umbilical vein

GO:0070374

PMID:21536891

CL:0002618

endothelial cell of umbilical vein

GO:0032088

PMID:25327529

CL:0002544

aortic endothelial cell

GO:0035924

PMID:21536891

CL:0002618

endothelial cell of umbilical vein

GO:1903589

PMID:21536891

CL:0002618

endothelial cell of umbilical vein

GO:0090050

PMID:21536891

CL:0002618

endothelial cell of umbilical vein

GO:0070374

PMID:21536891

CL:0002618

GO:0090050

PMID:18977327

CL:2000044

GO:0030949

PMID:18977327

CL:2000044

endothelial cell of umbilical vein
brain microvascular endothelial
cell
brain microvascular endothelial
cell
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artery
artery

hsa-miR-29a-3p
hsa-miR-29a-3p

artery

hsa-miR-29a-3p

artery

hsa-miR-29b-3p

artery

hsa-miR-29c-5p

artery

hsa-miR-29c-5p

artery

hsa-miR-30a-3p

artery

hsa-miR-30a-3p

artery

hsa-miR-30b-5p

artery

hsa-miR-30b-5p

artery
artery

hsa-miR-30b-5p
hsa-miR-30b-5p

artery

hsa-miR-30b-5p

artery

hsa-miR-30c-5p

artery

hsa-miR-30e-5p

artery
artery

hsa-miR-30e-5p
hsa-miR-31-5p

artery

hsa-miR-31-5p

artery

hsa-miR-31-5p

artery

hsa-miR-329-3p

artery

hsa-miR-329-3p

artery

hsa-miR-329-3p

negative regulation of angiogenesis
positive regulation of angiogenesis
positive regulation of G1/S transition of mitotic
cell cycle
negative regulation of collagen biosynthetic
process
negative regulation of angiogenesis
negative regulation of insulin-like growth factor
receptor signaling pathway
positive regulation of angiogenesis
transforming growth factor beta receptor
signaling pathway
negative regulation of angiogenesis
negative regulation of endothelial cell apoptotic
process
positive regulation of protein phosphorylation
positive regulation of sprouting angiogenesis
positive regulation of transforming growth factor
beta receptor signaling pathway
negative regulation of sprouting angiogenesis
negative regulation of endothelial cell apoptotic
process
negative regulation of sprouting angiogenesis
positive regulation of angiogenesis
positive regulation of blood vessel endothelial
cell migration
positive regulation of sprouting angiogenesis
negative regulation of cell migration involved in
sprouting angiogenesis
negative regulation of vascular endothelial
growth factor signaling pathway
NIK/NF-kappaB signaling

GO:0016525
GO:0045766

PMID:28637396
PMID:23541945

CL:0002618
CL:0002618

endothelial cell of umbilical vein
endothelial cell of umbilical vein

GO:1900087

PMID:23541945

CL:0002618

endothelial cell of umbilical vein

GO:0032966

PMID:22269326

CL:0002547

GO:0016525

GO:0045766

PMID:26175848
PMID:26045889
,PMID:2617584
8
PMID:23960241

CL:0002618
CL:0002618
,CL:000261
8
CL:0002618

fibroblast of the aortic
adventitia
endothelial cell of umbilical vein
endothelial cell of umbilical
vein,endothelial cell of umbilical
vein
endothelial cell of umbilical vein

GO:0007179

PMID:23960241

CL:0002618

endothelial cell of umbilical vein

GO:0016525

PMID:28977001

CL:0000071

GO:2000352

PMID:27464494

CL:2000018

GO:0001934
GO:1903672

PMID:28977001
PMID:23086751

CL:0000071
CL:0000071

blood vessel endothelial cell
endothelial cell of coronary
artery
blood vessel endothelial cell
blood vessel endothelial cell

GO:0030511

PMID:28977001

CL:0000071

blood vessel endothelial cell

GO:1903671

PMID:27780851

CL:0002618

GO:2000352

PMID:27464494

CL:2000018

GO:1903671
GO:0045766

PMID:27780851
PMID:28097093

CL:0002618
CL:0002618

endothelial cell of umbilical vein
endothelial cell of coronary
artery
endothelial cell of umbilical vein
endothelial cell of umbilical vein

GO:0043536

PMID:26933040

CL:0002618

endothelial cell of umbilical vein

GO:1903672

PMID:26933040

CL:0002618

endothelial cell of umbilical vein

GO:0090051

PMID:23878390

CL:0002618

endothelial cell of umbilical vein

GO:1900747

PMID:23878390

CL:0002618

endothelial cell of umbilical vein

GO:0038061

PMID:23878390

CL:0002618

endothelial cell of umbilical vein

GO:0043569

artery

hsa-miR-342-5p
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negative regulation of protein kinase B signaling
negative regulation of transforming growth
factor beta receptor signaling pathway
negative regulation of vascular endothelial
growth factor signaling pathway

GO:0051898

PMID:26857067

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-342-5p

GO:0030512

PMID:26857067

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-342-5p

GO:1900747

PMID:26857067

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-34a-5p

cellular response to hypoxia

GO:0071456

PMID:27302634

CL:0002591

artery

hsa-miR-34a-5p

negative regulation of angiogenesis

GO:0016525

PMID:24048733

CL:0002618

artery

hsa-miR-34a-5p

negative regulation of calcium ion import

GO:0090281

PMID:27302634

CL:0002591

artery

hsa-miR-34a-5p

GO:1903671

PMID:23426265

artery

hsa-miR-34a-5p

negative regulation of sprouting angiogenesis
negative regulation of vascular associated
smooth muscle cell migration

GO:1904753

PMID:26493107

artery

hsa-miR-34a-5p

artery

hsa-miR-361-5p

GO:0016525

PMID:24792364
,PMID:2649310
7
PMID:25203061

CL:0002618
UBERON:0
000947
CL:0002546
,UBERON:0
000947
CL:0000071

artery

hsa-miR-362-3p

GO:2000134

PMID:28890348

CL:0000359

artery
artery

hsa-miR-377-3p
hsa-miR-424-5p

GO:1903671
GO:0016525

PMID:25251394
PMID:28566713

CL:0002618
CL:0000071

blood vessel endothelial cell
vascular associated smooth
muscle cell
endothelial cell of umbilical vein
blood vessel endothelial cell

artery

hsa-miR-424-5p

GO:0090051

PMID:28566713

CL:0000071

blood vessel endothelial cell

artery

hsa-miR-424-5p

negative regulation of ERK1 and ERK2 cascade

GO:0070373

PMID:23263626

CL:1001568

artery

hsa-miR-424-5p

negative regulation of fibroblast growth factor
receptor signaling pathway

GO:0040037

PMID:21885851
,PMID:2326362
6

CL:0002544
,CL:100156
8

artery

hsa-miR-424-5p

negative regulation of G0 to G1 transition

GO:0070317

PMID:23263626

CL:1001568

artery

hsa-miR-424-5p

GO:1900747

PMID:21885851

CL:0002544

aortic endothelial cell

artery

hsa-miR-424-5p

GO:1904706

PMID:23263626

CL:0002591

smooth muscle cell of the
pulmonary artery

negative regulation of vascular smooth muscle
cell proliferation
negative regulation of angiogenesis
negative regulation of G1/S transition of mitotic
cell cycle
negative regulation of sprouting angiogenesis
negative regulation of angiogenesis
negative regulation of cell migration involved in
sprouting angiogenesis

negative regulation of vascular endothelial
growth factor signaling pathway
negative regulation of vascular smooth muscle
cell proliferation

GO:1904706

smooth muscle cell of the
pulmonary artery
endothelial cell of umbilical vein
smooth muscle cell of the
pulmonary artery
endothelial cell of umbilical vein
aorta
embryonic blood vessel
endothelial progenitor cell,aorta

pulmonary artery endothelial
cell
aortic endothelial
cell,pulmonary artery
endothelial cell
pulmonary artery endothelial
cell
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artery

hsa-miR-451a

artery

hsa-miR-4632-3p

artery

hsa-miR-483-5p

artery

hsa-miR-487b-3p

artery

hsa-miR-487b-3p

artery

hsa-miR-492

artery

hsa-miR-495-3p

artery

hsa-miR-495-3p

artery
artery

hsa-miR-503-5p
hsa-miR-503-5p

artery

hsa-miR-503-5p

artery

hsa-miR-503-5p

positive regulation of vascular associated
smooth muscle cell migration
cellular response to platelet-derived growth
factor stimulus
negative regulation of cell migration involved in
sprouting angiogenesis
positive regulation of blood vessel endothelial
cell proliferation involved in sprouting
angiogenesis
positive regulation of cell migration involved in
sprouting angiogenesis
negative regulation of angiogenesis
negative regulation of endothelial cell apoptotic
process
positive regulation of G1/S transition of mitotic
cell cycle
negative regulation of angiogenesis
negative regulation of cell-substrate adhesion
negative regulation of cell migration involved in
sprouting angiogenesis
negative regulation of endothelial cell migration

GO:1904754

PMID:25006399

UBERON:0
002012

GO:0036120

PMID:28701355

CL:0002591

smooth muscle cell of the
pulmonary artery

GO:0090051

PMID:21893058

CL:0000071

blood vessel endothelial cell

GO:1903589

PMID:25660232

CL:0002618

endothelial cell of umbilical vein

GO:0090050

PMID:25660232

CL:0002618

endothelial cell of umbilical vein

GO:0016525

PMID:23802567

CL:0002618

endothelial cell of umbilical vein

GO:2000352

PMID:25466836

CL:0002618

endothelial cell of umbilical vein

GO:1900087

PMID:25466836

CL:0002618

endothelial cell of umbilical vein

GO:0016525
GO:0010812

PMID:28566713
PMID:21220732

CL:0000071
CL:0002543

blood vessel endothelial cell
vein endothelial cell

GO:0090051

PMID:28566713

CL:0000071

blood vessel endothelial cell

GO:0010596

PMID:21220732

CL:0002543

negative regulation of ERK1 and ERK2 cascade

GO:0070373

PMID:23263626

CL:1001568

hsa-miR-503-5p

negative regulation of fibroblast growth factor
receptor signaling pathway

GO:0040037

PMID:23263626

CL:1001568

artery

hsa-miR-503-5p

negative regulation of G0 to G1 transition

GO:0070317

PMID:23263626

CL:1001568

artery

hsa-miR-503-5p

GO:1904706

PMID:23263626

CL:0002591

artery

hsa-miR-505-3p

GO:0016525

PMID:25449503

CL:0002618

vein endothelial cell
pulmonary artery endothelial
cell
pulmonary artery endothelial
cell
pulmonary artery endothelial
cell
smooth muscle cell of the
pulmonary artery
endothelial cell of umbilical vein

artery

hsa-miR-503-5p

artery

artery

hsa-miR-638

GO:2000134

PMID:23554459

CL:0002539

aortic smooth muscle cell

artery

hsa-miR-638

GO:0048008

PMID:23554459

CL:0002539

aortic smooth muscle cell

negative regulation of vascular smooth muscle
cell proliferation
negative regulation of angiogenesis
negative regulation of G1/S transition of mitotic
cell cycle
platelet-derived growth factor receptor signaling
pathway

pulmonary artery
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hsa-miR-92a-3p
hsa-miR-939-5p
hsa-miR-939-5p
hsa-let-7f-5p

negative regulation of canonical Wnt signaling
pathway
negative regulation of sprouting angiogenesis
cellular response to low-density lipoprotein
particle stimulus
negative regulation of inflammatory response
negative regulation of nitric oxide biosynthetic
process
positive regulation of interleukin-6 production
positive regulation of monocyte chemotactic
protein-1 production
positive regulation of sprouting angiogenesis
negative regulation of angiogenesis
negative regulation of cell-matrix adhesion
negative regulation of interleukin-17 production

blood

hsa-miR-106a-5p

blood

hsa-miR-144-3p

blood

hsa-miR-144-3p

blood

hsa-miR-144-3p

blood

hsa-miR-144-3p

blood

hsa-miR-146a-5p

blood

hsa-miR-146a-5p

blood

artery

hsa-miR-665

GO:0090090

PMID:29118903

CL:0002539

aortic smooth muscle cell

artery

hsa-miR-7-5p

GO:1903671

PMID:27431648

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-92a-3p

GO:0071404

PMID:24255059

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-92a-3p

GO:0050728

PMID:22267480

CL:1000413

endothelial cell of artery

artery

hsa-miR-92a-3p

GO:0045019

PMID:21768538

CL:0000071

blood vessel endothelial cell

artery

hsa-miR-92a-3p

GO:0032755

PMID:24255059

CL:0002618

endothelial cell of umbilical vein

artery

hsa-miR-92a-3p

GO:0071639

PMID:24255059

CL:0002618

endothelial cell of umbilical vein

artery
artery
artery
blood

GO:1903672
GO:0016525
GO:0001953
GO:0032700

PMID:26299712
PMID:28115160
PMID:28115160
PMID:21508257

CL:0002618
CL:0002618
CL:0002618
CL:0000813

negative regulation of interleukin-8 secretion

GO:2000483

PMID:26265888

CL:2000001

GO:0010886

PMID:24733347

CL:0000517

GO:0050718

PMID:24733347

CL:0000517

macrophage derived foam cell

GO:2000778

PMID:24733347

CL:0000517

macrophage derived foam cell

GO:1904469

PMID:24733347

CL:0000517

macrophage derived foam cell

GO:0010887

PMID:21329689

CL:0000517

macrophage derived foam cell

GO:1900016

PMID:29896267

CL:0000583

alveolar macrophage

hsa-miR-146a-5p

positive regulation of cholesterol storage
positive regulation of interleukin-1 beta
secretion
positive regulation of interleukin-6 secretion
positive regulation of tumor necrosis factor
secretion
negative regulation of cholesterol storage
negative regulation of cytokine production
involved in inflammatory response
negative regulation of inflammatory response

endothelial cell of umbilical vein
endothelial cell of umbilical vein
endothelial cell of umbilical vein
memory T cell
peripheral blood mononuclear
cell
macrophage derived foam cell

GO:0050728

hsa-miR-146a-5p

negative regulation of interleukin-6 secretion

GO:1900165

blood

hsa-miR-146a-5p

GO:2000483

blood

hsa-miR-146a-5p

negative regulation of interleukin-8 secretion
negative regulation of toll-like receptor 4
signaling pathway

CL:0000517
CL:0000517
,CL:000058
3
CL:0000517

macrophage derived foam cell

blood

PMID:21329689
PMID:21329689
,PMID:2989626
7
PMID:21329689

GO:0034144

PMID:21329689

CL:0000517

macrophage derived foam cell

macrophage derived foam
cell,alveolar macrophage
macrophage derived foam cell
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cellular response to low-density lipoprotein
particle stimulus
cholesterol homeostasis
negative regulation of inflammatory response
negative regulation of NF-kappaB transcription
factor activity
negative regulation of protein localization to
nucleus
negative regulation of tumor necrosis factor
production
negative regulation of defense response to
bacterium
negative regulation of innate immune response
negative regulation of phagocytosis
negative regulation of signal transduction
positive regulation of inflammatory response
cholesterol homeostasis
positive regulation of cytokine secretion
positive regulation of lipoprotein lipase activity
positive regulation of NIK/NF-kappaB signaling
transforming growth factor beta receptor
signaling pathway
positive regulation of B cell receptor signaling
pathway

blood

hsa-miR-155-5p

GO:0071404

PMID:21030878

CL:0000517

macrophage derived foam cell

blood
blood

hsa-miR-155-5p
hsa-miR-155-5p

GO:0042632
GO:0050728

PMID:21030878
PMID:21030878

CL:0000517
CL:0000517

macrophage derived foam cell
macrophage derived foam cell

blood

hsa-miR-155-5p

GO:0032088

PMID:21030878

CL:0000517

macrophage derived foam cell

blood

hsa-miR-155-5p

GO:1900181

PMID:21030878

CL:0000517

macrophage derived foam cell

blood

hsa-miR-181a-5p

GO:0032720

PMID:23516523

CL:0000235

macrophage

blood

hsa-miR-181b-5p

GO:1900425

PMID:25505240

CL:0000235

macrophage

blood
blood
blood
blood
blood
blood
blood
blood

hsa-miR-181b-5p
hsa-miR-181b-5p
hsa-miR-181b-5p
hsa-miR-181b-5p
hsa-miR-182-5p
hsa-miR-182-5p
hsa-miR-182-5p
hsa-miR-182-5p

GO:0045824
GO:0050765
GO:0009968
GO:0050729
GO:0042632
GO:0050715
GO:0051006
GO:1901224

PMID:25505240
PMID:25505240
PMID:25505240
PMID:25505240
PMID:28855441
PMID:28855441
PMID:28855441
PMID:28855441

CL:0000235
CL:0000235
CL:0000235
CL:0000235
CL:0000235
CL:0000235
CL:0000235
CL:0000235

macrophage
macrophage
macrophage
macrophage
macrophage
macrophage
macrophage
macrophage

blood

hsa-miR-183-5p

GO:0007179

PMID:24586048

CL:0000623

natural killer cell

blood

hsa-miR-19a-3p

GO:0050861

PMID:26017478

CL:2000001

GO:0050728

PMID:25084135
,PMID:2576559
6
PMID:28972028

CL:0000517
,CL:000051
7
CL:0000492

peripheral blood mononuclear
cell
macrophage derived foam
cell,macrophage derived foam
cell
CD4-positive helper T cell

blood

hsa-miR-19b-3p

cholesterol homeostasis

GO:0042632

blood

hsa-miR-20a-5p

blood

hsa-miR-20a-5p

blood

hsa-miR-20a-5p

negative regulation of inflammatory response
negative regulation of phosphatidylinositol 3kinase signaling
negative regulation of protein kinase B signaling

GO:0014067

PMID:28972028

CL:0000492

CD4-positive helper T cell

GO:0051898

PMID:28972028

CL:0000492

GO:0051607

PMID:26222045

CL:2000001

CD4-positive helper T cell
peripheral blood mononuclear
cell

blood

hsa-miR-26b-5p

defense response to virus

81

blood

hsa-miR-26b-5p

blood

hsa-miR-27a-5p

blood

hsa-miR-302a-3p

blood
blood
blood
blood

hsa-miR-302a-3p
hsa-miR-33b-5p
hsa-miR-361-5p
hsa-miR-488-3p

blood

hsa-miR-488-3p

blood
blood

hsa-miR-590-3p
hsa-miR-590-3p

blood

hsa-miR-758-3p

blood

hsa-miR-920

blood

hsa-miR-920

brain

hsa-miR-195-5p

heart

hsa-let-7b-5p

heart

hsa-miR-1-3p

heart
heart

hsa-miR-1-3p
hsa-miR-1-3p

heart

hsa-miR-1-3p

heart

hsa-miR-155-5p

heart

hsa-miR-155-5p

GO:0050687

PMID:26222045

CL:2000001

peripheral blood mononuclear
cell

GO:0071560

PMID:28791023

CL:0000623

natural killer cell

GO:0071404

PMID:25524771

CL:0000235

macrophage

GO:0042632
GO:0042632
GO:0050727
GO:0050728

PMID:25524771
PMID:24931346
PMID:28444107
PMID:28915828

CL:0000235
CL:0000581
CL:0000517
CL:0000235

macrophage
peritoneal macrophage
macrophage derived foam cell
macrophage

GO:0042536

PMID:28915828

CL:0000235

macrophage

GO:0042632
GO:0050728

PMID:25149060
PMID:25149060

CL:0000235
CL:0000235

macrophage
macrophage

GO:0071404

PMID:21885853

CL:0000235

macrophage

GO:0050728

PMID:28915828

CL:0000235

macrophage

GO:0042536

PMID:28915828

CL:0000235

macrophage

response to ischemia

GO:0002931

PMID:30497184

positive regulation of angiogenesis

GO:0045766

PMID:26296645

GO:0010614

PMID:19933931

GO:0001934
GO:1903672

PMID:19131648
PMID:23625462

UBERON:0
000955
UBERON:0
002349
UBERON:0
006566
CL:0000746
CL:0000513

GO:0010880

PMID:19131648

CL:0000746

cardiac muscle cell

GO:0090051

PMID:28408180

UBERON:0
000948

heart

GO:1903206

PMID:20550618

CL:0010021

cardiac myoblast

negative regulation of defense response to virus
cellular response to transforming growth factor
beta stimulus
cellular response to low-density lipoprotein
particle stimulus
cholesterol homeostasis
cholesterol homeostasis
regulation of inflammatory response
negative regulation of inflammatory response
negative regulation of tumor necrosis factor
biosynthetic process
cholesterol homeostasis
negative regulation of inflammatory response
cellular response to low-density lipoprotein
particle stimulus
negative regulation of inflammatory response
negative regulation of tumor necrosis factor
biosynthetic process

negative regulation of cardiac muscle
hypertrophy
positive regulation of protein phosphorylation
positive regulation of sprouting angiogenesis
regulation of release of sequestered calcium ion
into cytosol by sarcoplasmic reticulum
negative regulation of cell migration involved in
sprouting angiogenesis
negative regulation of hydrogen peroxideinduced cell death

brain
myocardium
left ventricle myocardium
cardiac muscle cell
cardiac muscle myoblast
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heart

hsa-miR-21-5p

heart

hsa-miR-223-3p

heart

hsa-miR-223-3p

kidney

hsa-miR-590-5p

liver
liver

hsa-miR-144-3p
hsa-miR-148a-3p

liver

hsa-miR-148a-3p

liver

hsa-miR-185-5p

liver

hsa-miR-199a-5p

liver
liver

hsa-miR-199a-5p
hsa-miR-21-5p

liver

hsa-miR-27a-3p

liver

hsa-miR-27b-3p

liver

hsa-miR-27b-3p

liver

hsa-miR-30c-5p

liver

hsa-miR-548p

muscle_skelet
al
muscle_skelet
al

regulation of calcium ion transmembrane
transport via high voltage-gated calcium channel
positive regulation of glucose import
positive regulation of protein localization to
plasma membrane
negative regulation of epithelial to mesenchymal
transition
cholesterol homeostasis
cholesterol homeostasis
negative regulation of low-density lipoprotein
particle clearance
negative regulation of low-density lipoprotein
particle clearance
negative regulation of low-density lipoprotein
particle clearance
negative regulation of receptor internalization
cellular response to virus
negative regulation of low-density lipoprotein
particle clearance
cholesterol homeostasis
negative regulation of low-density lipoprotein
particle clearance
negative regulation of fatty acid biosynthetic
process
negative regulation of fatty acid biosynthetic
process

GO:1902514

PMID:25107449

CL:0000746

cardiac muscle cell

GO:0046326

PMID:20080987

CL:0000746

cardiac muscle cell

GO:1903078

PMID:20080987

CL:2000046

ventricular cardiac muscle cell

GO:0010719

PMID:26459119

CL:1000497

kidney cell

GO:0042632
GO:0042632

PMID:23519695
PMID:26437365

CL:0000182
CL:0000182

hepatocyte
hepatocyte

GO:0010989

PMID:26437365

CL:0000182

hepatocyte

GO:0010989

PMID:26523989

CL:0000182

hepatocyte

GO:0010989

PMID:26163491

CL:0000182

hepatocyte

GO:0002091
GO:0098586

PMID:26163491
PMID:27571873

CL:0000182
CL:0000182

hepatocyte
hepatocyte

GO:0010989

PMID:26318398

CL:0000182

hepatocyte

GO:0042632

PMID:26520906

CL:0000182

hepatocyte

GO:0010989

PMID:26520906

CL:0000182

hepatocyte

GO:0045717

PMID:23749231

UBERON:0
002107

liver

GO:0045717

PMID:28336556

CL:0000182

hepatocyte

hsa-miR-15b-5p

positive regulation of translation

GO:0045727

PMID:25403480

CL:0000737

striated muscle cell

hsa-miR-16-5p

positive regulation of translation

GO:0045727

PMID:25403480

CL:0000737

striated muscle cell

GO:0045736

PMID:27343180

CL:0000540

neuron

GO:0010801

PMID:27343180

CL:0000540

neuron

nerve

hsa-miR-103a-3p

nerve

hsa-miR-103a-3p

negative regulation of cyclin-dependent protein
serine/threonine kinase activity
negative regulation of peptidyl-threonine
phosphorylation

nerve

hsa-miR-106b-5p

nerve

hsa-miR-106b-5p

nerve
nerve

hsa-miR-125b-13p
hsa-miR-125b-13p
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nerve

hsa-miR-132-3p

nerve

hsa-miR-132-3p

nerve

hsa-miR-132-3p

nerve
nerve
nerve

hsa-miR-140-5p
hsa-miR-146a-5p
hsa-miR-146a-5p

nerve

hsa-miR-15a-5p

nerve

hsa-miR-15a-5p

nerve

hsa-miR-212-3p

nerve

hsa-miR-212-3p

nerve

hsa-miR-212-3p

nerve

hsa-miR-218-5p

nerve

hsa-miR-29b-3p

nerve

hsa-miR-98-5p

skin

hsa-miR-181b-5p

cellular response to amyloid-beta
negative regulation of peptidyl-tyrosine
phosphorylation

GO:1904646

PMID:27520374

CL:0000540

neuron

GO:0050732

PMID:27520374

CL:0000540

neuron

positive regulation of protein phosphorylation

GO:0001934

PMID:28947385

CL:0000540

neuron

positive regulation of tau-protein kinase activity

GO:1902949

PMID:28947385

CL:0000540

neuron

GO:0051001

PMID:28089352

CL:0000540

neuron

GO:0045019

PMID:28089352

CL:0000540

neuron

GO:0033137

PMID:28089352

CL:0000540

neuron

GO:1904646
GO:0051898
GO:0043065

PMID:29253717
PMID:27241555
PMID:27241555

CL:0000540
CL:0000540
CL:0000540

neuron
neuron
neuron

GO:0045736

PMID:27343180

CL:0000540

neuron

GO:0010801

PMID:27343180

CL:0000540

neuron

GO:0051001

PMID:28089352

CL:0000540

neuron

GO:0045019

PMID:28089352

CL:0000540

neuron

GO:0033137

PMID:28089352

CL:0000540

neuron

GO:0032966

PMID:19913496

CL:0000122

stellate neuron

GO:0032966

PMID:19913496

CL:0000122

stellate neuron

GO:1904646

PMID:27541017

CL:0000540

neuron

GO:0034144

PMID:27641447

CL:0000312

keratinocyte

negative regulation of nitric-oxide synthase
activity
negative regulation of nitric oxide biosynthetic
process
negative regulation of peptidyl-serine
phosphorylation
cellular response to amyloid-beta
negative regulation of protein kinase B signaling
positive regulation of apoptotic process
negative regulation of cyclin-dependent protein
serine/threonine kinase activity
negative regulation of peptidyl-threonine
phosphorylation
negative regulation of nitric-oxide synthase
activity
negative regulation of nitric oxide biosynthetic
process
negative regulation of peptidyl-serine
phosphorylation
negative regulation of collagen biosynthetic
process
negative regulation of collagen biosynthetic
process
cellular response to amyloid-beta
negative regulation of toll-like receptor 4
signaling pathway

skin

hsa-miR-200b-3p

skin

hsa-miR-203a-3p

skin

hsa-miR-203a-3p

negative regulation of blood vessel endothelial
cell migration
negative regulation of cytokine production
involved in inflammatory response
negative regulation of interleukin-8 secretion

GO:0043537

PMID:22499991

UBERON:0
002067

dermis

GO:1900016

PMID:23608026

CL:0000312

keratinocyte

GO:2000483

PMID:23608026

CL:0000312

keratinocyte
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